This invention relates to centralized hospital monitoring systems and particular to the organization, analysis, and automatic detection of patterns indicative of upper airway instability during sleep, deep sedation, and analegia.
The high number of unnecessary deaths in the hospital due to errors related to pharmaceutical administration such as sedative and narcotics has been a recent focus of US government studies and much discussion in the literature and press. The present inventors recognized that these adverse events occur not only due to improper dosage of medications or the administration of drug to the wrong patient, as has been recently highlighted in the medical literature and press, but also due to failure to recognize complex patterns along monitored outputs (such as those shown in
In hospitals, throughout the United States monitored patients are experiencing profound physiologic instability before and during medication infusion producing patterns as shown in
A major factor in the development of respiratory failure (one of the most common causes of death in the hospital) is airway instability, which results in airway collapse during sedation, stroke, narcotic administration, or stupor. As illustrated in
This failure of conventional hospital based patient monitors to timely and/or automatically detect cluster patterns indicative of airway instability can be seen as a major health care deficiency indicative of a long unsatisfied need. Because obstructive sleep apnea, a condition derived from airway instability, is so common, the consequence of the failure of conventional hospital monitors to routinely recognize upper airway instability clusters means that many of patients with this disorder will never be diagnosed in their lifetime. For these patients, the diagnostic opportunity was missed and the health implications and risk of complications associated with undiagnosed airway instability and sleep apnea will persist in this group throughout the rest of their life. A second group of patients will have a complication in the hospital due to the failure to timely recognize airway instability. Without recognition of the inherent instability, a patient may be extubated too early after surgery or given too much narcotic (the right drug, the right patient, the ordered dose but unknowingly a “relative drug excess”). Indeed until clusters indicative of airway instability are routinely recognized by hospital monitors, the true incidence of respiratory failure, arrest, and/or death related to the administration of IV . . . sedation and narcotics to patients in the hospital with airway instability will never be known but the number is probably in the tens of thousands each year and airway instability is just one example of the types of physiologic instability which are not automatically characterized by central hospital systems.
To understand the criticality of recognizing airway instability in real-time it is important to consider the significance of the combined effect that oxygen therapy and narcotics or sedation may have in the patient care environment in the hospital, for example, in the management of a post-operative obese patient after upper abdominal surgery. Such a patient may be at particular risk for increased airway instability in association with narcotic therapy in the through 3rd post-operative day due to sleep deprivation, airway edema, and sedation. Furthermore, in the second and third postoperative day monitoring the vigilance of hospital personnel may diminish due to perceived stability, and rebound rapid eye movement (REM) sleep which can increase upper airway instability may occur due to antecedent sleep deprivation. Indeed, many of these patients have significant sleep apnea prior to admission to the hospital which is unknown to the surgeon or the anesthesiologist due to the subtly of symptoms. Such patients, even with severe sleep apnea, are relatively safe at home because of an intact arousal response; however, in the hospital, narcotics and sedatives often remove this “safety net. The administration of post-operative narcotics can shift the arousal curve to the right and this can significantly increase the danger of airway instability and, therefore, place the patient at substantial risk. Many of these patients are placed on electrocardiographic monitoring but the alarms are generally set at high and low limits. Hypoxemia, induced by airway instability generally does not generally produce marked levels of tachycardia; therefore, airway instability is poorly identified by simple electrocardiographic monitoring without the identification of specific pattern of clusters of the pulse rate. In addition, simple oxiretry evaluation is also a poor method to identify airway instability. Conventional hospital oximeters often have averaging intervals, which attenuate the dynamic desaturations. Even when the clustered desaturations occur they are often thought to represent false alarms because they are brief. When desaturations are recognized as potentially real this often results in the simple and often misguided addition of nasal oxygen. However, nasal oxygen may prolong the apneas and potentially increase functional airway instability. From a monitoring perspective, the addition of oxygen therapy can be seen to potentially hide the presence of significant airway instability by attenuation of the level of desaturation and reduction in the effectiveness of the oximeter as a monitoring tool in the diagnosis of this disorder.
Oxygen and sedatives can be seen as a deadly combination in patients with severely unstable airways since the sedatives increase the apneas and the oxygen hides them from the oximeter. For all these reasons, as will be shown, according to the present invention, it is critical to monitor patients with increased risk of airway instability for the specific monomorphic and polymorphic cluster patterns as will be discussed, during the administration of narcotics or sedatives.
Having identified, supra, the long and critical need, a discussion of the background physiology of upper airway instability will first be provided.
The central drive to breath, which is suppressed by sedatives or narcotics, basically controls two critical muscle groups. The upper airway “dilator muscles” and the diaphragm “pump muscles”. The tone of both these muscle groups must be coordinated. A fall in afferent output from the brain controller to the airway dilators results in upper airway collapse. Alternatively, a fall in afferent output to the pump muscles causes hypoventilation.
Two major factors contribute to respiratory arrest in the presence of narcotic administration and sedation. The first and most traditionally considered potential effect of narcotics or sedation is the suppression by the narcotic or sedative of the brains afferent output to pump muscle such as the diaphragm and chest wall, resulting in inadequate tidal volume and associated fall in minute ventilation and a progressive rise in carbon dioxide levels. The rise in carbon dioxide levels causes further suppression of the arousal response, therefore, potentially causing respiratory arrest. This first cause of respiratory arrest associated with sedation or narcotics has been the primary focus of previous efforts to monitor patients postoperatively for the purpose of minimization of respiratory arrests. Both oximetry and tidal CO2 monitoring have been used to attempt to identify and prevent this development. However, in the presence of oxygen administration, oximetry is a poor indicator of ventilation. In addition, patients may have a combined cause of ventilation failure induce by the presence of both upper airway instability and decreased diaphragm output as will be discussed, this complicates the output patterns of CO2 monitors making recognition of evolving respiratory failure due to hypoventilation more difficult for conventional threshold alarm based systems.
The second factor causing respiratory arrest due to narcotics or sedatives relates to depression of the brains afferent output to upper airway dilator muscles causing a reduction in upper airway tone. This reduction in airway tone results in dynamic airway instability and precipitates monomorphic cluster cycles of airway collapse and recovery associated with the arousal response as the patient engages in a recurrent and cyclic process of arousal based rescue from each airway collapse. If, despite the development of significant cluster of airway collapse, the narcotic administration or sedation is continued, this can lead to further prolongation of the apneas, progression to dangerous polymorphic desaturation, and eventual respiratory arrest. There is, therefore, a dynamic interaction between suppression of respiratory drive, which results in hypoventilation and suppression of respiratory drive, which results in upper airway instability. At any given time, a patient may have a greater degree of upper airway instability or a greater degree of hypo ventilation. The relative combination of these two events will determine the patterns of the output of the monitor.
Unfortunately, this has been one of the major limitations of carbon dioxide monitoring. The patients with significant upper airway obstruction are also the same patients who develop significant hypo ventilation. The upper airway obstruction may result in drop out of the nasal carbon dioxide signal due to both the upper airway obstruction, on one hand, or due to conversion from nasal to oral breathing during a recovery from the upper airway obstruction, on the other hand. Although breath by breath monitoring may show evidence of apnea, conversion from nasal to oral breathing can reduce the ability of the CO2 monitor to identify even severe hypoventilation in association with upper airway obstruction, especially if the signal is averaged or sampled at a low rate. For this reason, conventional tidal CO2 monitoring when applied with conventional monitors without out cluster pattern recognition may be least effective when applied to patients at greatest risk, that is, those patients with combined upper airway instability and hypoventilation. The present inventors recognized that this unique physiologic process of reentry of airway collapse could be exploited to provide a system and method for the recognition of the waveform patterns of airway instability. Several early embodiments are described in U.S. Pat. No. 6,223,064 (which is assigned to the present inventor, the disclosure and the entire contents of which are incorporated by reference is if completely disclosed herein). These systems and methods exploit the underlying cyclic physiologic process, which drives the perpetuation of a cluster of airway closures, to provide automatic recognition and indication of upper airway instability in real time. As discussed, the underlying cyclic process, which defines the behavior of the unstable upper airway, is associated with precipitous changes in ventilation and attendant precipitous changes in monitored parameters, which reflect and/or are induced by such ventilation changes. For example, cycling episodes of airway collapse and recovery produces sequential precipitous changes in waveform output defining analogous cluster waveforms in the time series of: oximetry derived pulse, airflow amplitude or/or tidal frequency, the oximetry SpO2, the chest wall impedance and/or motion. EKG pulse rate, and/or R to R interval, EEG (due to clustering of arousals), EMG due to clustering of motor response to arousals, systolic time intervals, and other parameters which vary with the brisk clustered cycles of apnea and recovery. EEG is readily available in the hospital as BIS monitors, according to the present invention the detection of clusters of alpha or high amplitude, mixed frequency arousals in clusters is very useful to indicate the potential presence of airway instability. According to the present invention, anyone of these parameters singularly or in combination can be used in the hospital to detect either the absolute presence of airway instability or to provide evidence of probable airway instability so that hospital personnel know that additional testing should be applied.
Conventionally, in the hospital, the analysis of one or more time series datasets is widely used to characterize the behavior of physiologic systems and to identify the occurrence adverse events. One basic conventional hospital montage commonly connected to a central monitor by telemetry includes electrocardiogram (EKG), pulse oximetry, and chest wall impedance). Using this grouping of monitors, the human physiologic system produces a large array of highly interactive time series outputs, the dynamic relational configurations of which have substantial relevance when monitored over both brief and long time intervals. The present inventors recognized that multiple unique patterns of airway instability were present along the time series and that these different patterns could be identified to provide an interpretive output such a textual output and/or other alarm. In addition, the present inventors recognized that the complexity and time course variability of these patterns commonly overwhelms hospital workers so that timely intervention is often not applied, resulting in unnecessary death or patient injury. The inventors further recognized that the processed based recognition of these patterns could be used to take action in the interest of the health of the patient, such as automatically lock out narcotic or sedation medication or increase the level and/or type of ventilation support. They also recognized that combined central and satellite processing systems such as those used in the hospital based systems discussed supra, could be modified to provide such automatic recognition and to provide such output and/or take such action to improve the health care of patients such as automatically locking out a drug infusion’ upon the recognition of the interval development of an unstable pattern potentially indicative of an adverse drug reaction or titration of continuous positive pressure devices. The invention also provides a method of doing business to improve the sale of patient monitoring systems, CPAP, and disposable probes for use with the monitors.
According one aspect of the present invention, the recognition of sequential precipitous events or pathophysiologic patterns can be achieved by analyzing the spatial and/or temporal relationships between at least a portion of a waveform of a physiology parameter, (such as, for example, those listed supra), induced by at least a first episode of airway collapse and at least a portion of a waveform induced by at least a second episode of airway collapse. This can include the recognition of a pattern indicative of a cluster, which can compromise a high count of apneas with specified identifying features which occur within’ a short time interval along said waveform (such as 3 or more apneas within about 5-10 minutes) and/or can include the identification of a waveform pattern defined by closely spaced episodes of airway collapse defining waveform clusters. Further, the recognition can include the identification of a spatial and/or temporal relationship defined by waveform clusters, which are generated by closely spaced sequential apneas due to cycling upper airway collapse and recovery.
According to another aspect of the invention, the patterns of these complex interactive signals and the data sets defining path physiologic upper airway instability are characterized by organizing the time series into an ascending hierarchy of objects (which in one preferred embodiment are substantially in the time domain), ordering these objects into a relational data matrix and then recognizing the complex reciprocations across time series and across scales and by applying an expert system to that set of highly organized set of objects.
For the purpose of organizing and identifying physiologic datasets, according to the present invention a fundamental dynamic time series object is identified and characterized, which possesses a unique symmetry of scale. The inventors call this object a “physiologic reciprocation”. For the purpose of pattern recognition, according to the present invention, a physiologic reciprocation is a fundamental variation time series output generated by an organ, an organ system, and/or an entire organism, which is at least partially reversed within a specified interval. According to the present invention reciprocations, as recognized by the processor, are widely scalable across substantially all fundamental output patterns of organ function and physiologic control. The present inventors recognized that an scaleable system which recognized and analyzed reciprocations along a time series, across different scales of the time series, and between different scales of different contemporaneously derived time series, could be used to readily identify specific dynamic physiologic patterns of interaction defining both different states of disease and health. Further, the present inventors recognized that, for the purpose of processor based pattern recognition, human physiologic function (and dysfunction) can be characterized by defining and recognizing a object hierarchy of physiologic reciprocations ordered into an ascending, inheritance based relational timed data matrix.
Using the above discoveries the present inventors recognized that typical standard central hospital monitors including those with wireless capabilities (such as the system described for example U.S. Pat. No. 6,364,834) and outpatient holter type monitors can be improved to provide automatic recognition of airway instability and sleep apnea and to provide an automatic visual or audible indication of the presence of such clusters and further to provide a visual or audible output and severity of this disorder thereby rendering the timely recognition and diagnosis of upper airway instability and obstructive sleep apnea as routine and automatic in the hospital as the diagnosis of other common diseases such as hypertension.
a illustrates the reentry process driving the propagation of airway instability reentry clusters. The physiologic basis for these clusters has been previously described in U.S. Pat. Nos. 5,891,023 and 6,223,064 and provisional application 60/291,691 (the entire contents of each of which are incorporated by reference as if completely disclosed herein). This cycle is present when the airway is unstable but the patient is capable of arousal. In this situation, in the sleeping or sedated patient, upon collapse of the airway, the patient does not simply die, she rescues herself and precipitously opens the airway to recover by hypoventilation. however, if the airway instability remains after the arousal and rescue is over, the airway collapses again, only to be rescued again thereby producing a cluster of closely spaced apneas with distinct spatial, frequency and temporal waveform relationships between and within apneas wherein the physiologic process reenters again and again to produce a clustered output. According to the present invention, an airway instability cluster is comprised of a plurality (two or more) of closely spaced apneas or hypopneas but the use of 3 or more apneas is preferred. The present invention includes (but is not limited to) recognition of airway instability clusters in oxygen saturation, pulse, chest wall impedance, blood pressure, airflow (including but not limited to exhaled carbon dioxide and air temperature). nasal and oral pressure, systolic time intervals, electrocardiograph tracings (including pulse rate and R to R interval plots), timed plots of ST segment position, chest wall and/or abdominal movements (as by strain gauge, impendence, or other methods), electromyography (EMG), and electroencephalography (EEO). For all of these waveforms the basic underlying cluster pattern is similar and the same basic presently preferred cluster pattern recognition system and method, according to the present invention, can be applied to recognize them.
According to one aspect of the invention, a microprocessor system is provided for the recognition of specific dynamic patterns of interaction between a plurality of corresponding and related time series, the system comprises a processor programmed to; process a first time series to produce a lower-level time series of sequential time series fragments derived from the first time series, process the lower-level time series to produce a higher-level time series comprised of sequential time series fragments from the lower-level time series, process a second time series, the second time series being related to the first time series, produce a second lower-level time series of sequential time series fragments derived from the second time series, and identify a dynamic pattern of interaction between the first time series and the second time series. The system can be further programmed to process the lower-level time series of the second time series to; produce a higher-level time series derived from sequential time series fragments of the second lower-level, time series. The system can be programmed to process a third time-series, the third time series being related to at least one of the first and the second time series, to produce a third lower-level time series of sequential time series fragments derived from said third time series. The system can be programmed to process the higher-level time series to produce a complex-level time series derived from sequential time series fragments of said higher-level time series. The time series fragments of the first and second time series can be stored in a relational database, the fragments of the higher-level time series can comprise objects, the objects inheriting the characteristics of the objects of the lower-level time series from which they are derived. The first and second time series can comprise datasets of physiologic data points and the system can comprise a patient monitoring system wherein the dynamic pattern of interaction comprises convergent clusters of pathologic reciprocations.
It is the purpose of the present invention to provide a diagnostic system, which can convert conventional hospital-based central telemetry and bard wired monitoring systems and portable home systems to provide processor based recognition of airway instability through the recognition of patterns of closely spaced reciprocations and/or events induced by apneas and/or hypopneas both in real time and in overnight interpretive format and which can automatically lock-out narcotic infusion upon recognition of patterns of instability.
It is the purpose of the present invention to provide a system, which identifies, maps, and links waveform clusters of airway instability from simultaneously derived timed signals of multiple parameters including chest wall movement, pulse, airflow, exhaled carbon dioxide, systolic time intervals, oxygen saturation, EKG-ST segment level, EEG, EMG, and other parameters to enhance the real-time and overnight diagnosis of airway instability.
It is further the purpose of the present invention to provide a system to provide a graded index and/or indication of patterns of airway instability.
It is further the purpose of the present invention to provide a system, which provides characterization of different types of patterns of ventilation and/or upper airway instability.
It is further the purpose of the present invention to provide a system, which provides characterization and/or differentiation of different types of patterns such as monomorphic, polymorphic, and combined patterns of instability.
It is further the purpose of the present invention to provide a system, which provides characterization to output an indication of the type of pattern identified by the processor so that a decision relevant the probability of success of auto titration with CPAP and/or BIPAP can be made.
It is further the purpose of the present invention to provide timely, real-time indication such as a warning or alarm of the presence of airway instability clusters so that nurses can be aware of the presence of a potentially dangerous instability of the upper airway during titration of sedatives and/or narcotics.
It is further the purpose of the present invention to provide a system for the recognition of airway instability for combined cluster mapping of a timed dataset of nasal oral pressure with tidal CO2 to identify clusters of conversion from nasal to oral breathing and to optimally recognize clusters indicative of airway instability in association with tidal CO2 measurement indicative of hypoventilation.
It is the purpose of the present invention to provide an iterative object oriented waveform processing system, which can characterize, organize, and compare multiple signal levels across a plurality of signals by dividing each waveform level of each signal into objects for discretionary comparison within a relational database, object database or object relational database.
It is further the purpose of the present invention to provide a system, which automatically triggers lockout of medication infusion based on the recognition of an adverse pattern of instability along at least one timed dataset output.
It is another, aspect of the present invention to provide a system that automatically customizes treatment algorithms or diagnostic algorithms based on the analysis of waveforms of the monitored parameters.
It is further the purpose of the present invention to provide a system, which provides recognition and characterization of physiologic reciprocations across different time series scales.
It is further the purpose of the present invention to provide a system, which automatically triggers testing (and comparison of the output) of a secondary intermittently testing monitor upon the recognition of patterns indicative of physiologic instability.
It is further the purpose of the present invention to provide real time protection to patients against adverse drug and to provide a data matrix comprising matched time series of physiologic signals with a time series of drug infusion so that hospital personnel can readily match specific patterns of pathophysiologic perturbations to specific types of medications and ranges of medication dosage for patients hospital wide.
a shows an illustration of the complexity of the mechanisms defining the timed interactions of physiologic systems induced by upper airway instability, which the present inventor calls an “airway instability cluster reentry cycle” showing the derivative reciprocations, which are generated by the cycling producing the corresponding cluster of reciprocations.
b shows a schematic object mapping at the composite level of two simultaneously measured parameters, which are perturbed to produce clusters in response to the upper airway instability cycles of
c shows an example of a monomorphic cluster pattern indicative of airway instability and derived from the mechanism of
d shows another example of monomorphic cluster pattern derived from the mechanism of
e shows a schematic representation of a portion of a multi-signal object as derived from the multiple corresponding time series of
a shows a typical monomorphic airway instability cluster along times series of oximetry, airflow, and thorax movement.
b shows a polymorphic airway instability cluster along times series of oximetry, airflow, and thorax movement.
c shows a times series of oximetry over a period of about 2 hours and 40 minutes demonstrating a monomorphic airway instability cluster of negative oxygen saturation reciprocations degenerating into a polymorphic cluster exhibiting marked instability of control evidenced by marked reciprocations of the peaks and nadirs of the negative oximetry reciprocations within the cluster. This represents a markedly adverse pathophysiologic pattern, which is automatically recognized and graded according to the present invention.
d shows a 16.2-minute segment of the times series of oximetry of
e shows a 12.S-minute segment of a times series of oximetry illustrating a more severe decline of the peaks comprising degeneration into a polymorphic pattern indicative of severely adverse pathophysiologic pattern and which can be indicative of an important decline in arousal threshold and incompletes arousal response which fails to completely correct the negative reciprocation. This polymorphic pattern is automatically recognized according to the present invention to provide an output indication or to take action such as to lock out medication.
e shows a 19.2-minute segment of a time series of oximetry illustrating a modest variation of the peaks of reciprocations with negative reciprocations of the nadirs each said reciprocation becoming more negative. This peak variation is consistent with a mild polymorphic cluster. Note that the variations of the nadirs can be indicative of an important instability and decline in arousal threshold despite a complete or nearly complete arousal response. This pattern is automatically recognized according to the present invention to provide an output indication or to take action such as to lock out medication.
One presently preferred system for processing, analyzing and acting-on a time series of multi-signal objects is shown in
In one example the occurrence of a dynamic clustering of apneas can be identified and the infusion pump (which can be for example a patient controlled analgesia (PCA) device can be automatically locked out to prevent further infusion and ad an output such as “Caution—pattern suggestive of mild upper airway instability at dose of 1 mg Morphine.” If in this example the nurse increases the dose to 2 milligram and the pattern shows an increase in severity an output such as “Pattern suggestive of moderated upper airway instability at dose of 2 mg/hr. of Morphine-morphine locked out”. To maintain Morphine dose at the 2 mg. level for this patient, the nurse or physician would have to override the lockout and preferably document the reason for override. Upon an override the processor then tracks the severity of the clusters and if the clusters reaches an additional severity threshold an output such as “Severe upper airway instability—Morphine locked out” is provided. According to the present invention the onset of the drug administration is recognized by the central processor and the dose administered becomes a time series, which can then be matched to the patterns of the monitored physiologic time series. In addition to real time protection, the data matrix comprising matched time series of physiologic signals with a time series of drug infusion provides an ability for hospital personnel to readily match specific patterns of pathophysiologic perturbations to specific types of medications and ranges of medication dosage for patients hospital wide.
The composite object level is comprised of sequential and overlapping composite objects, and particularly reciprocations, which are composed, of a specific sequence of dipoles as defined by selected criteria. Each of these composite objects has similar primary characteristics of a slope, duration, and polarity to the fundamental objects. However, for the composite objects, the characteristic of slope can comprise a time series characteristic given as a slope dataset. The composite object level also has the characteristic of “intervening interval time-series” defined by a time series of the intervals between the recognized or selected composite objects. At this level a wide range of discretionary index characteristics can be derived from the comparison of basic characteristics of composite objects. Examples of such index characteristics include; a “shape characteristic” as derived from any specified portion of the slope dataset of the object, a “positional characteristic” as derived from, for example, the value of the lowest or highest points of the object, or a “dimensional value characteristic” as derived by calculating the absolute difference between specified data points such as the value of the lowest and the highest values of the object, or a “frequency characteristic” such as may be derived from performing a Fourier transform on the dataset of the object.
The next analysis level is called the “complex object level”. In this level, each sequential complex object comprises plurality of composite objects meeting specific criteria. According to the present invention, the patterns of reciprocations at the complex level are representative of a balance between physiologic perturbation and the control. As such they are useful to characterize the integrity of control of the organism as well as the severity and character of the perturbation. According to the present invention, complex physiologic reciprocations are generally derived from composite level reciprocations and inherit their characteristics. Therefore a complex object (such as a recovery object) inherits the composite (tidal breath) reciprocations from which it is derived and this is exploited by the system as will be discussed. Complex objects have the same categories of primary characteristics and derived index characteristics as a composite object. A complex object also has the additional characteristics of “composite object frequency” or “composite object order” which can be used as search criteria as part of an overlaid expert system. These can be defined by a selected frequency or order of composite object types, which are specified as defining a given complex object. A complex object also has additional higher-level characteristics defined by the time-series of the shapes, dimensional values, and positional characteristics of its component composite objects. As described for the composite objects, similar index characteristics of the complex objects can be derived from these characteristics for example; a complex object can be derived as a cluster of composite level reciprocations.
In a further example a complex level reciprocation given by a time series of positional characteristic along a clustered grouping of sequential composite objects (such a reciprocation object derived of sequential nadir points or characteristics of composite level reciprocations of a cluster object at the complex level) can be readily identified and characterized.
Characteristics or index characteristics may be combined with others. For example, a shape characteristic (which contains the slope data set in the time domain) may be combined with a frequency characteristic to provide a time series of a mathematical index of the slopes and the frequencies of the composite objects which can be ordered in an object hierarchy of ascending object data sets and correlated with other object level of other object data sets.
The next level, termed the “global objects level” is then derived from the time series of complex objects. At this level global characteristics are derived from the time series datasets of complex objects (and all of their characteristics). At the global objects level, the processor can identify general specific patterns over many hours of time. An example of one specific pattern which is readily recognizable at this level would be a pattern of regular monotonous occurrence of negative reciprocations alternating with positive reciprocations at the complex level comprised of composite objects, wherein the composite objects are derived of regular reciprocations of negative reciprocations alternating with positive reciprocations (of tidal breathing) at the composite level and wherein the magnitude of both the negative and positive reciprocations at the composite level oscillates in a regular frequency. This pattern is typical of Cheyenne-Stokes Respirations and according to the present invention an expert system examines the pattern of the objects at the composite level, the complex level, and finally at the global level to provide distinction between this process and the patterns of upper airway instability.
Additional higher levels can be provided if desired as by a “comprehensive objects level” (not shown), which can, for example, include multiple overnight, or post operative monitoring periods wherein a comprehensive object is comprised of a dataset of “global objects”.
While
a shows an exemplary pathophysiologic process associated with a characteristic dynamic pattern of interaction. As discussed previously, this cyclic process is induced by upper airway instability producing derivative reciprocations across a wide range of physiologic parameters.
c, and 10a show examples of a monomorphic cluster pattern indicative of airway instability and derived from the mechanism of
In the presently preferred embodiment, the time series of each of these signals are processed into time domain fragments (as objects) and organized into the object levels as previously discussed. For the purpose of organizing and analyzing complex interactions between these corresponding and/or simultaneously derived signals, the same basic ascending process is applied to each signal. As shown in
This type of representation is too complex for presentation to hospital personnel but is preferred for the purpose of general representation of the data organization because, at this level of complexity, a complete representation of multiple time series does not lend itself well to a two-dimensional graphical (and in some cases a three dimensional) representation.
To illustrate the complexity ordered by this approach, consider the components of just one of the three simple recovery objects shown in
As is readily apparent, it is not possible for a health care worker to timely evaluate the values or relationships of even a modest fraction of these parameters and an expert system applied generally to these parameters rapidly becomes inordinately complex and cumbersome. For this reason the output based on the analysis of these time series of objects are optimally first ordered into a relational, inheritance based object hierarchy, and then subjected to expert system analysis and/or presented in a succinct and interpretive format to the hospital worker as will be discussed.
One of the longstanding problems associated with the comparison of outputs of multiple sensors to derive simultaneous multiple time series outputs for the detection of pathophysiologic change is that the accuracy and/or output of each sensor may be affected by different physiologic mechanisms in different ways. Because of this, the value of matching an absolute value of one measurement to an absolute value of another measurement is degraded. This is particularly true if the measurement technique or either of the values is imprecise. For example, when minute ventilation is measured by a precise method such as a pneumotachometer, then the relationship between the absolute values of the minute ventilation and the oxygen saturation are particularly relevant. However, if minute ventilation is being trended as by nasal thermister or nasal pressure monitoring or by chest wall impedance, then the absolute values become much less useful. However, according to one aspect of the present invention the relationship between pluralities of simultaneously derived signals can be determined independent of the relationships of the absolute values of the signals. In this way, simultaneously derived signals can be identified as having convergence consistent with physiologic subordination or divergent shapes consistent with the development of a pathologic relationship or inaccurate data acquisition.
As noted, with physiologically linked signals, a specific occurrence or magnitude of change in one signal in relationship to such a change in another signal may be more important and much more reproducible than the absolute value relationships of the respective signals. Using the teachings of the present invention, two simultaneously acquired and physiologically linked signals are compared by the microprocessor over corresponding intervals by matching the respective objects (which can be applied at multiple levels) between the signals. As discussed, a primary signal such as airflow is ordered into composite and complex objects along with a contemporaneously measured secondary signal such as oxygen saturation as by the method and system discussed previously. For example, the composite level of airflow can be a of reciprocation objects derived from a fundamental level of amplitude and/or frequency of the tidal airflow as by thermister or pressure sensor, or another plot, which is indicative of the general magnitude of the timed tidal airflow. In the presently preferred embodiment, a plot at the fundamental level of a mathematical index (such as the product) of the frequency and amplitude is preferred, because such an index takes into account the important attenuation of both amplitude and frequency during obstructive breathing. Furthermore, both the frequency and amplitude are often markedly increased during the recovery interval between apneas and hypopneas.
Although the exact delay between the signals may not be known, the processor can identify this by identifying the best match between the object sets. In the preferred embodiment, this “best match” is constrained by preset limits. For example, with respect to ventilation and oximetry, a preset limit could be provided in the range of 10-40 seconds although other limits could be used depending on the hardware, probe site and averaging intervals chosen. After the best match is identified, the relationships between the signals are compared (for example, the processor can compare the a rise or fall event of oxygen saturation to a rise or fall event of ventilation as shown in
It is not necessary that such a fundamental level plot reflect exactly the true value of the minute ventilation but rather, it is important that the plot reflect the degree of change of a given level of minute ventilation. Since these two signals are physiologically linked, an abrupt change in the primary signal (airflow) generally will produce readily identifiable change in the subordinate signal (oxygen saturation). As previously noted, since the events which are associated with airway collapse are precipitous, the onset of these precipitous events represent a brief period of rapid change which allows for optimal detection of the linkage between the primary signal and the subordinate signal.
The signals can be time matched by dipole slopes at the fundamental level. In addition, in one preferred embodiment, the point of onset of precipitous change is identified at the composite object level of the primary signal and this is linked to a corresponding point of a precipitous change in the composite object level of the subordinate signal. This is referred to herein as a delta point. As shown in
Using one presently preferred method, a first object (such as is shown in
Once the signals have been sufficiently matched at the one object level they can be further matched at another object level. When the objects are matched, the baseline dynamic range relationship between the signals can be determined. This baseline range relationship can be a magnitude value relationship or a slope relationship. The signals can then be monitored for variance from this baseline range, which can indicate pathology or signal inaccuracy. The variance from baseline can be, for example, an increase in the relative value of ventilation in relation to the oximetry value or a greater rate of fall in oxygen saturation in relation to the duration and/or slope of fall of ventilation. In another example, the variance can include a change from the baseline delay between delta points along the signals or a change in the direction (polarity) of one signal in relation to the baseline relationship for example two signals which formally moved in the same direction (after adjusting for a delay) may be recognized to exhibit variance by moving in opposite directions and the occurrence of this variance from a previously identified dynamic relationship (or a pre specified dynamic relationship range) Upon such recognition, according to the present inventor, the processor can be programmed to take action such as lock out a medication, adjust the flow of oxygen, change the positive pressure or tidal volume of a ventilator, or provide an indication, such as an alarm.
According to the present invention, clusters of signal perturbation induced by even mild hypopneas can generally be reliably recognized by their cluster patterns utilizing with only a single parameter without setting up a priori and arbitrary rules (such as a 50% reduction in the airflow signal). In addition, when significant signal noise or reduced gain is present reducing cluster recognition in one signal, the objects based system can combine matched clusters within a time series of multi-signal objects in the presence of sub optimal signals by providing a scoring system for sequential objects across a wide range of parameters.
The reciprocations are counted in sequence for each matched cluster object. For the purpose of illustration, according to the present invention, the occurrence of a score of 3 in anyone signal (meaning that a continuous sequence of 3 reciprocations meeting criteria have occurred within a specified interval) provides sufficient evidence to identify a cluster object. When two simultaneous signals are processed, a total score of 4, derived from adding the number of reciprocations meeting criteria in each signal, is sufficient to indicate the presence of a cluster object. In this manner the cluster is continued by a sequential unbroken count greater than 3 with one signal. or greater than 4 with two signals. Once the presence of a cluster object has been established along the time series, at any point along the cluster object the sequential count along one signal can be converted to a continuation of the sequential count along another signal allowing the cluster object to continue unbroken. The failure of the occurrence of a cycle meeting criteria within either signal within a specified interval (for example about 90-120 seconds, although other intervals may be used) breaks the cluster object. A new cluster object is again identified if the count again reaches the thresholds as noted above. It can be seen that this scoring method takes into account the fact that artifact often affects one signal and not another. Therefore if either signal alone provides a sufficient score, the presence of a cluster object is established. In addition, the effect of brief episodes of artifact affecting both signals is reduced by this scoring method. In this way, artifact, unless prolonged, may cause the cluster object to be broken but as soon as the artifact has reduced sufficiently in anyone or more signals the process of scoring for a new cluster object will restart. The skilled artisan will recognize that many other such scoring or artifact rejecting methods using two linked signals can be derived within the scope of this teaching.
When applied, one preferred digital pattern recognition program for automatically detecting, characterizing and indexing the severity airway instability proceeds in several phases, which need not be in the illustrative sequence, listed below:
1. Various types of decline and rise objects are identified at the composite level.
2. Various types of negative and positive reciprocations are identified at the composite level.
3. Various types of clusters of reciprocations are identified in the complex level.
4. Various types of reciprocations of clustered reciprocation object characteristics (e.g. nadirs) are identified,
6. Reciprocations at the fundamental level are analyzed within specific objects at the composite level.
7. Objects of one channel are compared to objects of another channel (if multiple time series of objects are rendered).
8. An expert system is applied to recognize a pattern of objects indicative of a diagnosis.
9. The relationship between the events, reciprocations, and complex patterns is calculated and outputted.
10. The severity of the pathophysiologic perturbation is determined
11. A textual alarm and/or other signal, which may be graded based on severity is outputted
12. Treatment is automatically modified to adjust or prevent medication infusion or to eliminate the cluster
13. The process is then repeated with each addition to the dataset in real-time or with stored timed datasets.
A mathematical representation of a basic iterative process of waveform object segmentation according to the present invention is described in detail in the co-pending application entitled System and Method for Identifying Dynamic Patterns of Interaction, the disclosure of which is incorporated by reference as if completely disclosed herein and an exemplary mathematical reference listing is provided in
The present inventors have described clusters comprised of reciprocations of varied morphology as polymorphic (an example of such a cluster is shown in figure t Ob). For the purpose of the presently preferred embodiment, with respect to the oximetry time series, a polymorphic cluster is a cluster of reciprocations, which contains at least two reciprocation morphologies and wherein the morphologies have differences other than simple variations in scale. In one embodiment, with respect to the oximetry time series, variation of the nadirs of the negative reciprocations is considered still consistent with monomorphic clusters. However in this embodiment, negative reciprocations of the peaks exceeding a 6% variation is considered indicative of a polymorphic cluster. Many modifications and different definitions can be applied to differentiate polymorphic from monomorphic clusters. In one preferred embodiment, the morphology of different reciprocation types is selectable by selecting the characteristics of the events from which they are derived (the reciprocations inheriting these characteristics). A monomorphic cluster may degenerate into a polymorphic cluster, and again this is recognized by identifying the presence of new types of reciprocations or events developing along the cluster. For example the occurrence of brief reciprocations with progressively falling peaks coupled with prolonged reciprocations with prolonged decline components would be one example of morphology of a polymorphic cluster. The present inventors recognized that reciprocation morphology was a window into the integrity and function of the control system. For this reason, the automatic recognition, according to the present invention provides an important function since the presence of a polymorphic cluster can indicate a control system which is highly unstable, severely attenuated, the presence of competing control systems (which can indicate partial attenuation of a primary controller and salvage by a secondary controller, or it can indicate that multiple pathophysiologic process are overlapping).
The present inventors have discover that, at least in one population of patients with airway instability, the basic monomorphic pattern dominates and polymorphic patterns occur in less than 10% of the patients. However, this may increase with narcotic administration or with select subgroups of the severe obesity (at risk for obesity hypoventilation syndrome) or those with COPD, or CHF. The present inventors have discovered that the automatic recognition of complex polymorphic clusters can be useful to determine the stability and integrity of ventilation control and the probability of success of automatic CPAP titration. This is an important discovery because primary care physicians have been reluctant to institute automatic CPAP in the home without attendance because the probability of success for a given patient cannot be known a priori. The present inventors recognized that the presence of polymorphic clusters and/or monomorphic clusters superimposed on other reciprocations (an occurrence which develops, for example, when airway instability is superimposed on other cardiovascular and pulmonary co morbidities) have a lower probability of successful automatic CPAP titration and are therefore may best titrated in a sleep laboratory or other attended setting where a trained attendant can adjust treatment. They also recognized that polymorphic reciprocations are often best treated with multilevel ventilation because they often indicate an incomplete, or delayed recovery, which is often best supported by ventilation rather than simple CPAP.
According to the present invention, a automatic CPAP titration which can use any of a range of algorithms for CPAP adjustment, as are known in the art, upon recognition by the processor of polymorphic clusters, or the presence of a decline in a time series of the peaks of clusters (as for example in the oximetry signal), and/or the failure to abort clusters, the processor is programmed to automatically converts the CPAP to a bi level ventilator. According to the present invention, this can be achieved by automatically lowering the pressure on exhalation by for example 2-4 cm H2O and maintaining the original pressure on inhalation. Alternatively, the processor can trigger the addition of higher pressure on inspiration, for example 2 cm H2O, above the original continuous pressure level and then titration of the inspiratory pressure and or expiratory pressure until the cluster is aborted. According to the present invention, if pathophysiologic divergence is identified with a fall in oxygen saturation in relation to a rise in ventilation (as discussed in detail in the aforementioned co-pending application) this recognition can be used to automatically warn of the potential need for oxygen or to automatically initiate or increase oxygen instead of increasing the CPAP or Ventilation. Also the development of pathophysiologic divergence in association with upward titration can be used to reduce the pressure to their original levels. Automatic conversion to ventilation or increasing ventilation upon the occurrence of polymorphic clusters and/or when the cluster peaks exhibit a significant decline or automatically aborting the titration and/or providing an output indication that the patterns indicate that attended titration may be preferable provides a more physiologically focused titration of therapy which can substantially improve the efficacy and sale of automatic positive pressure treatment devices.
According to the present invention, a wide range of variations of events, reciprocations and clusters are built from simpler objects and this provides the ability to identify a wide range of physiologic phenomena without losing information gained by aggregating specific types of such phenomena. For this reason the presently preferred time domain analysis starts with a basic segmentation process upon which is built a more complex characterization. The more complex physiologic occurrences are better represented programmatically than mathematically and this representation follows. Because the wide range of permutations causes marked complexity, the present inventors recognized that an effective framework and methodology was required to address the complexity of this type of software system. In the presently preferred embodiment object oriented time series segmentation, in the time domain, into an inheritance based relational hierarchy allows recognition and characterization a very broad range of real-world phenomena including complex, interactive physiological datasets.
The diagram of
The core objects of the presently preferred analysis are shown in
Since the creation of hundreds of thousands of dipole objects can hamper the acquisition of the analysis in a real-time environment, in the presently preferred embodiment, the logical concept of the dipole object has been encapsulated within the time series to improve performance in a real time environment.
Correlated events provide the basic mechanism for identifying relationship between channels. The aggregation of these objects within a case analysis object provides the ability to interpret broad, intra and inter-channel trends while also providing access to the large amount of simple objects and raw data from which those trends were derived. according to the present invention this presently preferred structure in the context of an object-oriented programming language that provides the power to readily apply a broad range of expert system based comparisons, create indices, alarms, graphical representations and other human facing mechanisms for interpretation and analysis.
As a further example, the following is a list of functions available for a cluster object (this does not include the ability of that object to access any functionality of the reciprocations, events and time series which are related to the cluster object):
As shown, in the above structure a requesting system will create an analysis request and submit it to the case analysis director. The director is a dispatcher object that oversees the analysis process while delegating the actual processing to other objects. The most important of these delegates is the channel analysis builder. This object performs the basic algorithms described above against the respective time series to produce the aforementioned events, reciprocations, clusters and the relationships between them.
During this process data structures for providing fast access by point and dipole are created as point and dipole maps respectively. These objects provide single step access to all objects tied to a particular point and/or dipole. This supports a high level of interactivity (e.g. mouse over actions) in a graphic user interface (e.g. a Microsoft Windows application).
Analysis requests may not be comprehensive and therefore further analysis can be requested to the case analysis director. This ability to provide partial analysis further enhances performance by allowing a researcher or physician to specify the particular aspects of the analysis he/she finds useful.
The channel integrator performs intra-channel analysis to create event correlations. These correlations (and the aggregations thereof) provide an integrated view of all channels within a case.
Of course, the transformation itself can be a quite complex process and the transform has a substantial impact on the waveform morphology and relationships. This has been a significant problem with standard hospital monitoring systems (such as pulse oximeters). Despite the importance of the effect a transform has on time series morphology and alarm reliability the monitoring industry has not standardized to any transform and many oximeters do not even provide documentation relevant the transform applied to generate the time series. The present inventors recognized that, in the interest of providing optimal patient care, the transform needs to be understood by the physician and researcher so that the time series outputs and all algorithms performed are clearly identified and/or can be explicitly requested. For this purpose, the present inventors created a nomenclature for explicit representation of an transformations available.
According to the present invention, objects at the composite level encapsulate the objects from which they are derived at the fundamental level. For this reason a recovery object recognized at the composite level in one parameter can used to specify a region for comparison of sequential objects (such as reciprocations) at the fundamental object level in the same parameter or in matched recovery objects along another parameter. For example, upon recognition of the presence of a recovery object (where. it is anticipated that the ventilation effort will be high) the ratio of the slope off all (exhalation) objects and rise (inhalation) objects at the fundamental level can be compared within the recovery object and the time series derived from an continuous calculation this ratio can be plotted at it too analyzed by object mapping if desired. During upper airway obstruction, the inspiration is slowed to a greater degree than exhalation. The magnitude change of inspiratory slowing and/or amplitude and/or ratio during the clusters of apneas provides an index of the magnitude of upper airway narrowing (which slows inhalation during the clustered apnea/hypopnea objects). However, during the recovery object or at the “hyperventilation reference point”, the upper airway should be wide open for both inhalation and exhalation and this can be used as a reference because, during this time. Because the recovery objects encapsulate the fundamental reciprocation objects from which it is derived, the absolute slope, magnitude, frequency and amplitude, of the fundamental objects during recovery can then be compared to provide a reference for the absolute slope magnitude, frequency and amplitude of the fundamental objects during other times along the night to provide an indication of upper or lower airway narrowing.
These encapsulations allow ready exploitation that certain regions along a multi-signal object (as within an airway instability cluster) have a very high probability of association with various levels of ventilation. According to the present invention, the objects defining those regions can then be used as a reference or as an opportunity to examine for the effects of a given level of ventilation effort on the flow characteristics of the encapsulated reciprocations. Patients with obstructive sleep apnea are expected to have a hill in the slopes of fundamental inspiration objects during decline objects at the composite level indicative of upper airway narrowing and/or occlusion. Also, as shown in
Another example of object processing at the fundamental object level, according to the present invention, includes the processor-based identification of fluttering of the plateau on the pressure signal to recognize partial upper airway obstruction. During the nasal pressure monitoring a fluttering plateau associated with obstructive breathing often occurs intervening a rise event and a fall event of tidal breathing. Since the plateau objects are easily recognizable at the fundamental level and readily separated using the present object recognition system the plateau can be processed for the tiny rise and fall objects associated with fluttering and the frequency of these objects can be determined. Alternatively, a Fourier transform can be applied to the plateau objects between the rise and fall events of the nasal pressure signal to recognize the presence of fluttering or another method can be utilized which provides an index of the degree of fluttering of the plateau objects.
Since reduced effort also lowers the slope of exhalation and inspiration, the configuration (as defined by the slope dataset of the dipoles defining the fundamental objects of both inspiration and expiration at the reference objects) can be applied as reference fundamental object configurations defining the presence of hyperventilation or hypopnea. This process is similar to the selection process for identifying search objects described earlier but in this case the input region is pre-selected. In an example, the range of characteristics of the objects at the fundamental level derived from one or more tidal breaths occurring prior to the second airflow delta point can be used to designate a reference hyperventilation objects range. Alternatively the object based characteristics, defined by of the range of characteristics of the objects derived from one or more tidal breaths occurring prior to the first airflow delta point can be used designate a reference hypopnea objects range. The processor can then automatically assess object ranges along other points of the tracing. In this way the processor can apply an artificial intelligence process to the identification of hypopneas by the following process:
In one embodiment, the multi-signal time series output is placed into a format particularly useful for demonstrating events to hospital personal especially for teaching purposes. In this format the output controls an animation of multiple objects which are shaped into an animated schematic of the as the physiologic system being monitored. The animation moves over time and in response to the signals and one preferred embodiment the type of signals (or the reliability of such signals) determines which components of the schematic are “turned on” and visible. One example includes a multi-signal object defined by outputs of airflow, thoracic impedance, oximetry, and blood pressure rendering set of a connected set animation objects for the lungs, upper airway, lower airway, heart, and blood vessels which can be animated as;
This provides “physiologic animation” which can be monitored in real-time and which can also be derived and reviewed from the stored multi-signal objects at variable time scales. This embodiment of the present invention provides a quickly, easily understood and dynamic animated output of a highly complex, interactive time series derived from a patient. The animation can be reviewed at an increased time lapsed to speed through evolution of a given patients outputs or can be slowed or stopped to see the actual global physiologic state at the point of onset or termination of a given pathophysiologic perturbation.
Particularly for use in the hospital, a graded indicator or alarm can be provided, indicative of the severity of the clusters and of air way or ventilation instability. Since very mild clustering may simply represent the effect of moderate sedation, and not, therefore, represent a cause for great concern (although it is important to recognize that it is present). Such a clustering could be identified with a single bar or test warning, whereas more severe clustering would generate a larger warning and, if very severe, an auditory alarm. When the clustering becomes more severe and demonstrates greater levels of desaturation and/or shorter recovery intervals the bar can be doubled.
According to another aspect of the present invention, a change in one or more time series components of the multi-signal object can be used to change the processing algorithm of a time series component of the multi-signal object. In an example, the recognition of airway instability is enhanced by improved fidelity of the timed waveform (as with pulse oximetry).
The present invention thereby provides for more optimal continuous fidelity of the waveform through both motion and non-motion states. As illustrated in
Those skilled in the art will recognize that, the information provided from the data and analysis generated from the above-described system can form the basis for other hardware and/or software systems and has wide potential utility. Devices and/or software can provide input to or act as a consumer of the physiologic signal processing system of the present invention's data and analysis.
The following are examples of presently preferred ways that the present physiologic signal processing system can interact with other hardware or software systems:
It is anticipated that the physiologic signal processing system will be used in these and many other ways. To facilitate this anticipated extension through related hardware and software systems the present system will provide an application program interface (API). This API can be provided through extendable source code objects, programmable components and/or a set of services. Access can be tightly coupled through software language mechanisms (e.g. a set of C++ modules or Java classes) or proprietary operating system protocols (e.g. Microsoft's DCOM, OMG's CORBA or the Sun Java Platform) or can be loosely coupled through industry standard non-proprietary protocols that provide real-time discovery and invocation (e.g. SOAP [Simple Object Access Protocol] or WSDL [Web Service Definition Language]).
In the preferred embodiment the physiologic signal processing system with the API as defined becomes a set of programmable objects providing a feature-rich development and operating environment for future software creation and hardware integration.
a-19e presents one presently preferred programming code for integrating a plurality of signals and identifying dynamic patterns of interaction. The program is particularly suited for physiologic signals but can be used to track and identify relationships between a broad range of signals to identify specific patterns or to search for patterns. Although the listed program is coded for contiguous points for efficiency, according to the present invention, the time series data points need not be contiguous and indeed as discussed with physiologic data sets, noncontiguous points are converted into a time series when nadirs or peaks of reciprocations are plotted to identify timed patterns of variation in these parameters. The present invention is applicable to detect dynamic patterns and relationships particularly in the time domain in the along and between one or a plurality of financial time series such as stock prices or stock indexes, vibration time series, time series of sound, air movement, temperature, populations, and other dynamic processes where it may be desirable to identify, along complex data sets, known or unknown dynamic patterns of interaction.
Although the presently preferred embodiments have been described, which relate to the processing of physiologic signals, it is also critical to recognize the present streaming parallel objects based data organization and processing method can be used to order and analyze a wide range of dynamic patterns of interactions across a wide range of corresponding signals and data sets in many environments. The invention is especially applicable to the monitoring of the variations or changes to a physical system, biologic system, or machine subjected to a specific process or group of processes over a specific time interval.
Many other additional parameters may be added and will become evident to those skilled in the art in association with the application of the present invention and these are included within the scope of this invention. Those skilled in the art that various changes and modifications can be made without departing from the invention. While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
This application claims priority of prior application Ser. No. 11/369,355, filed Mar. 7, 2006; application Ser. No. 10/150,582, filed May 17, 2002; provisional applications 60/291,692 and 60/291,687, both filed May 17, 2001 and provisional application 60/295,484 filed Jun. 10, 2001, the disclosures and contents of each of which is incorporated by reference as if completely disclosed herein.
Number | Name | Date | Kind |
---|---|---|---|
3638640 | Shaw | Feb 1972 | A |
3646606 | Buxton | Feb 1972 | A |
3884219 | Richardson et al. | May 1975 | A |
3926177 | Hardway et al. | Dec 1975 | A |
3999537 | Noiles | Dec 1976 | A |
4036211 | Veth et al. | Jul 1977 | A |
4141354 | Ismach | Feb 1979 | A |
4202353 | Hirsch et al. | May 1980 | A |
4340044 | Levy et al. | Jul 1982 | A |
4696307 | Montgieux | Sep 1987 | A |
4714341 | Hamaguri | Dec 1987 | A |
4800495 | Smith | Jan 1989 | A |
4805623 | Jobis | Feb 1989 | A |
4807631 | Hersh et al. | Feb 1989 | A |
4838275 | Lee | Jun 1989 | A |
4846195 | Alt | Jul 1989 | A |
4911167 | Corenman et al. | Mar 1990 | A |
4913150 | Cheung et al. | Apr 1990 | A |
4936679 | Mersch | Jun 1990 | A |
4938218 | Goodman et al. | Jul 1990 | A |
4971062 | Hasebe et al. | Nov 1990 | A |
4972331 | Chance | Nov 1990 | A |
4974591 | Awazu et al. | Dec 1990 | A |
4995400 | Boehringer et al. | Feb 1991 | A |
5028787 | Rosenthal et al. | Jul 1991 | A |
5065749 | Hasebe et al. | Nov 1991 | A |
5066859 | Karkar et al. | Nov 1991 | A |
5072737 | Goulding | Dec 1991 | A |
5084327 | Stengel | Jan 1992 | A |
5092326 | Winn et al. | Mar 1992 | A |
5094246 | Rusz et al. | Mar 1992 | A |
5119815 | Chance | Jun 1992 | A |
5122974 | Chance | Jun 1992 | A |
5123420 | Paret | Jun 1992 | A |
5143078 | Mather et al. | Sep 1992 | A |
5167230 | Chance | Dec 1992 | A |
5190038 | Polson et al. | Mar 1993 | A |
5218962 | Mannheimer et al. | Jun 1993 | A |
5238001 | Gallant et al. | Aug 1993 | A |
5246003 | DeLonzor | Sep 1993 | A |
5247931 | Norwood | Sep 1993 | A |
5253645 | Friedman et al. | Oct 1993 | A |
5263244 | Centa et al. | Nov 1993 | A |
5269310 | Jones et al. | Dec 1993 | A |
5279295 | Martens et al. | Jan 1994 | A |
5285783 | Secker | Feb 1994 | A |
5297548 | Pologe | Mar 1994 | A |
5309908 | Friedman et al. | May 1994 | A |
5312454 | Roline et al. | May 1994 | A |
5329931 | Clauson et al. | Jul 1994 | A |
5355880 | Thomas et al. | Oct 1994 | A |
5372136 | Steuer et al. | Dec 1994 | A |
5385143 | Aoyagi | Jan 1995 | A |
5390666 | Kimm et al. | Feb 1995 | A |
5390670 | Centa et al. | Feb 1995 | A |
5413099 | Schmidt et al. | May 1995 | A |
5423327 | Clauson et al. | Jun 1995 | A |
5469845 | DeLonzor et al. | Nov 1995 | A |
5482036 | Diab et al. | Jan 1996 | A |
5483646 | Uchikoga | Jan 1996 | A |
5520176 | Cohen | May 1996 | A |
5553614 | Chance | Sep 1996 | A |
5558086 | Smith et al. | Sep 1996 | A |
5564417 | Chance | Oct 1996 | A |
5575285 | Takanashi et al. | Nov 1996 | A |
5584298 | Kabal | Dec 1996 | A |
5605151 | Lynn | Feb 1997 | A |
5611337 | Bukta | Mar 1997 | A |
5619991 | Sloane | Apr 1997 | A |
5630413 | Thomas et al. | May 1997 | A |
5645059 | Fein et al. | Jul 1997 | A |
5645060 | Yorkey | Jul 1997 | A |
5660171 | Kimm et al. | Aug 1997 | A |
5680857 | Pelikan et al. | Oct 1997 | A |
5692503 | Kuenstner | Dec 1997 | A |
5716384 | Snell | Feb 1998 | A |
5724580 | Levin et al. | Mar 1998 | A |
5730124 | Yamauchi | Mar 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5769082 | Perel | Jun 1998 | A |
5779631 | Chance | Jul 1998 | A |
5782757 | Diab et al. | Jul 1998 | A |
5786592 | Hok | Jul 1998 | A |
5800348 | Kaestle | Sep 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5830136 | DeLonzor et al. | Nov 1998 | A |
5830139 | Abreu | Nov 1998 | A |
5831598 | Kauffert et al. | Nov 1998 | A |
5840019 | Wirebaugh | Nov 1998 | A |
5842981 | Larsen et al. | Dec 1998 | A |
5846190 | Woehrle | Dec 1998 | A |
5862802 | Bird | Jan 1999 | A |
5871442 | Madarasz et al. | Feb 1999 | A |
5873821 | Chance et al. | Feb 1999 | A |
5891022 | Pologe | Apr 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5931790 | Peel, III | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5995855 | Kiani et al. | Nov 1999 | A |
5995856 | Mannheimer et al. | Nov 1999 | A |
5995859 | Takahashi | Nov 1999 | A |
6002952 | Diab et al. | Dec 1999 | A |
6004276 | Wright et al. | Dec 1999 | A |
6011986 | Diab et al. | Jan 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6050951 | Friedman et al. | Apr 2000 | A |
6064898 | Aldrich | May 2000 | A |
6067462 | Diab et al. | May 2000 | A |
6070098 | Moore-Ede et al. | May 2000 | A |
6081742 | Amano et al. | Jun 2000 | A |
6083172 | Baker, Jr. et al. | Jul 2000 | A |
6088607 | Diab et al. | Jul 2000 | A |
6095984 | Amano et al. | Aug 2000 | A |
6102038 | DeVries | Aug 2000 | A |
6102870 | Edwards | Aug 2000 | A |
6120460 | Abreu | Sep 2000 | A |
6134460 | Chance | Oct 2000 | A |
6141590 | Renirie et al. | Oct 2000 | A |
6150951 | Olejniczak | Nov 2000 | A |
6151516 | Kiani-Azarbayjany et al. | Nov 2000 | A |
6154667 | Miura et al. | Nov 2000 | A |
6163715 | Larsen et al. | Dec 2000 | A |
6171258 | Karakasoglu et al. | Jan 2001 | B1 |
6181958 | Steuer et al. | Jan 2001 | B1 |
6181959 | Schollermann et al. | Jan 2001 | B1 |
6190324 | Kieval et al. | Feb 2001 | B1 |
6215403 | Chan et al. | Apr 2001 | B1 |
6230035 | Aoyagi et al. | May 2001 | B1 |
6230142 | Benigno et al. | May 2001 | B1 |
6230708 | Radko | May 2001 | B1 |
6266546 | Steuer et al. | Jul 2001 | B1 |
6285895 | Ristolainen et al. | Sep 2001 | B1 |
6312393 | Abreu | Nov 2001 | B1 |
6322515 | Goor et al. | Nov 2001 | B1 |
6353750 | Kimura et al. | Mar 2002 | B1 |
6360114 | Diab et al. | Mar 2002 | B1 |
6363270 | Colla et al. | Mar 2002 | B1 |
6364834 | Reuss et al. | Apr 2002 | B1 |
6371114 | Schmidt et al. | Apr 2002 | B1 |
6385589 | Trusheim et al. | May 2002 | B1 |
6393311 | Edgar, Jr. et al. | May 2002 | B1 |
6397091 | Diab et al. | May 2002 | B2 |
6397092 | Norris et al. | May 2002 | B1 |
6397099 | Chance | May 2002 | B1 |
6398727 | Bui et al. | Jun 2002 | B1 |
6411833 | Baker, Jr. et al. | Jun 2002 | B1 |
6415166 | Van Hoy et al. | Jul 2002 | B1 |
6415175 | Conley et al. | Jul 2002 | B1 |
6415236 | Kobayashi et al. | Jul 2002 | B2 |
6419671 | Lemberg | Jul 2002 | B1 |
6425861 | Haberland et al. | Jul 2002 | B1 |
6438399 | Kurth | Aug 2002 | B1 |
6449501 | Reuss | Sep 2002 | B1 |
6461305 | Schnall | Oct 2002 | B1 |
6466809 | Riley | Oct 2002 | B1 |
6475153 | Khair et al. | Nov 2002 | B1 |
6487439 | Skladnev et al. | Nov 2002 | B1 |
6501974 | Huiku | Dec 2002 | B2 |
6501975 | Diab et al. | Dec 2002 | B2 |
6526301 | Larsen et al. | Feb 2003 | B2 |
6542764 | Al-Ali et al. | Apr 2003 | B1 |
6544193 | Abreu | Apr 2003 | B2 |
6546267 | Sugiura et al. | Apr 2003 | B1 |
6549795 | Chance | Apr 2003 | B1 |
6553242 | Sarussi | Apr 2003 | B1 |
6571622 | Koch | Jun 2003 | B2 |
6572557 | Tchou et al. | Jun 2003 | B2 |
6579242 | Bui et al. | Jun 2003 | B2 |
6580086 | Schultz et al. | Jun 2003 | B1 |
6591122 | Schmitt | Jul 2003 | B2 |
6594513 | Jobsis et al. | Jul 2003 | B1 |
6606509 | Schmitt | Aug 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6615064 | Aldrich | Sep 2003 | B1 |
6618042 | Powell | Sep 2003 | B1 |
6622095 | Kobayashi et al. | Sep 2003 | B2 |
6641542 | Cho et al. | Nov 2003 | B2 |
6654621 | Palatnik et al. | Nov 2003 | B2 |
6654624 | Diab et al. | Nov 2003 | B2 |
6658276 | Kianl et al. | Dec 2003 | B2 |
6658277 | Wasserman | Dec 2003 | B2 |
6659961 | Robinson | Dec 2003 | B2 |
6662030 | Khalil et al. | Dec 2003 | B2 |
6662032 | Gavish et al. | Dec 2003 | B1 |
6668183 | Hicks et al. | Dec 2003 | B2 |
6671526 | Aoyagi et al. | Dec 2003 | B1 |
6671528 | Steuer et al. | Dec 2003 | B2 |
6678543 | Diab et al. | Jan 2004 | B2 |
6684090 | Ali et al. | Jan 2004 | B2 |
6690958 | Walker et al. | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
6699194 | Diab et al. | Mar 2004 | B1 |
6708048 | Chance | Mar 2004 | B1 |
6711424 | Fine et al. | Mar 2004 | B1 |
6711425 | Reuss et al. | Mar 2004 | B1 |
6714245 | Ono | Mar 2004 | B1 |
6721584 | Baker, Jr. et al. | Apr 2004 | B2 |
6723077 | Pickup et al. | Apr 2004 | B2 |
6731274 | Powell | May 2004 | B2 |
6738666 | Park et al. | May 2004 | B1 |
6752150 | Remmers et al. | Jun 2004 | B1 |
6785568 | Chance | Aug 2004 | B2 |
6793654 | Lemberg | Sep 2004 | B2 |
6801797 | Mannheimer et al. | Oct 2004 | B2 |
6801798 | Geddes | Oct 2004 | B2 |
6801799 | Mendelson | Oct 2004 | B2 |
6810277 | Edgar, Jr. et al. | Oct 2004 | B2 |
6816266 | Varshneya et al. | Nov 2004 | B2 |
6820618 | Banner et al. | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6829496 | Nagai et al. | Dec 2004 | B2 |
6830549 | Bui et al. | Dec 2004 | B2 |
6836679 | Baker, Jr. et al. | Dec 2004 | B2 |
6839581 | El-Solh et al. | Jan 2005 | B1 |
6850053 | Daalmans et al. | Feb 2005 | B2 |
6863652 | Huang et al. | Mar 2005 | B2 |
6869402 | Arnold | Mar 2005 | B2 |
6873865 | Steuer et al. | Mar 2005 | B2 |
6889153 | Dietiker | May 2005 | B2 |
6898451 | Wuori | May 2005 | B2 |
6918878 | Brodnick | Jul 2005 | B2 |
6928370 | Anuzis et al. | Aug 2005 | B2 |
6931268 | Kiani-Azarbayjany et al. | Aug 2005 | B1 |
6931269 | Terry | Aug 2005 | B2 |
6934570 | Kiani et al. | Aug 2005 | B2 |
6939307 | Dunlop | Sep 2005 | B1 |
6947780 | Scharf | Sep 2005 | B2 |
6949081 | Chance | Sep 2005 | B1 |
6961598 | Diab | Nov 2005 | B2 |
6963767 | Rantala et al. | Nov 2005 | B2 |
6983178 | Fine et al. | Jan 2006 | B2 |
6985762 | Brashears et al. | Jan 2006 | B2 |
6993371 | Kiani et al. | Jan 2006 | B2 |
6994675 | Sharrock | Feb 2006 | B2 |
6996427 | Ali et al. | Feb 2006 | B2 |
7013898 | Rashad et al. | Mar 2006 | B2 |
7024235 | Melker et al. | Apr 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
7030749 | Al-Ali | Apr 2006 | B2 |
7031857 | Tarassenko et al. | Apr 2006 | B2 |
7034692 | Hickle | Apr 2006 | B2 |
7035679 | Addison et al. | Apr 2006 | B2 |
7035697 | Brown | Apr 2006 | B1 |
7040315 | Stromberg | May 2006 | B1 |
7044917 | Arnold | May 2006 | B2 |
7047056 | Hannula et al. | May 2006 | B2 |
7081095 | Lynn et al. | Jul 2006 | B2 |
7090648 | Sackner et al. | Aug 2006 | B2 |
7118534 | Ward et al. | Oct 2006 | B2 |
7123950 | Mannheimer et al. | Oct 2006 | B2 |
7127278 | Melker et al. | Oct 2006 | B2 |
7130671 | Baker | Oct 2006 | B2 |
7139599 | Terry | Nov 2006 | B2 |
7153263 | Carter et al. | Dec 2006 | B2 |
7161484 | Tsoukalis | Jan 2007 | B2 |
7162306 | Caby et al. | Jan 2007 | B2 |
7171269 | Addison et al. | Jan 2007 | B1 |
7181264 | Wiesmann | Feb 2007 | B2 |
7186217 | Kawasaki | Mar 2007 | B2 |
7188621 | DeVries et al. | Mar 2007 | B2 |
7190261 | Al-Ali | Mar 2007 | B2 |
7190995 | Chervin et al. | Mar 2007 | B2 |
7209775 | Bae et al. | Apr 2007 | B2 |
7218966 | Haefner | May 2007 | B2 |
7220220 | Stubbs et al. | May 2007 | B2 |
7222623 | DeVries et al. | May 2007 | B2 |
7222624 | Rashad et al. | May 2007 | B2 |
7225013 | Geva et al. | May 2007 | B2 |
7230529 | Ketcherside et al. | Jun 2007 | B2 |
7231240 | Eda et al. | Jun 2007 | B2 |
7236811 | Schmitt | Jun 2007 | B2 |
7239905 | Kiani-Azarbayjany et al. | Jul 2007 | B2 |
7263395 | Chan et al. | Aug 2007 | B2 |
7267652 | Coyle et al. | Sep 2007 | B2 |
7272426 | Schmidt et al. | Sep 2007 | B2 |
7277752 | Matos | Oct 2007 | B2 |
7297119 | Westbrook et al. | Nov 2007 | B2 |
7309314 | Grant et al. | Dec 2007 | B2 |
7338447 | Phillips | Mar 2008 | B2 |
7353054 | Kawasaki et al. | Apr 2008 | B2 |
7355512 | Al-Ali | Apr 2008 | B1 |
7366569 | Belalcazar | Apr 2008 | B2 |
7367339 | Hickle | May 2008 | B2 |
7367954 | Starr et al. | May 2008 | B2 |
7370650 | Nadjafizadeh et al. | May 2008 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
7398115 | Lynn | Jul 2008 | B2 |
7407485 | Huiku | Aug 2008 | B2 |
7407486 | Huiku et al. | Aug 2008 | B2 |
7421296 | Benser et al. | Sep 2008 | B1 |
7431696 | Brady et al. | Oct 2008 | B1 |
7447541 | Huiku et al. | Nov 2008 | B2 |
7460909 | Koh et al. | Dec 2008 | B1 |
7465555 | Anderson et al. | Dec 2008 | B2 |
7488293 | Marcovecchio | Feb 2009 | B2 |
7499835 | Weber | Mar 2009 | B2 |
7539537 | Hickle | May 2009 | B2 |
7544190 | Pickup et al. | Jun 2009 | B2 |
7635337 | Huika et al. | Dec 2009 | B2 |
7640055 | Geva et al. | Dec 2009 | B2 |
7645573 | Ivey et al. | Jan 2010 | B2 |
7647185 | Tarassenko et al. | Jan 2010 | B2 |
7668579 | Lynn | Feb 2010 | B2 |
7674230 | Reisfeld | Mar 2010 | B2 |
7725146 | Li et al. | May 2010 | B2 |
7758503 | Lynn et al. | Jul 2010 | B2 |
7767395 | Garrett et al. | Aug 2010 | B2 |
7785262 | Melker et al. | Aug 2010 | B2 |
7794406 | Reisfeld et al. | Sep 2010 | B2 |
7803118 | Reisfeld et al. | Sep 2010 | B2 |
7803119 | Reisfeld | Sep 2010 | B2 |
7806832 | Gallagher et al. | Oct 2010 | B2 |
7970725 | Armstrong et al. | Jun 2011 | B2 |
8274360 | Sampath et al. | Sep 2012 | B2 |
8414488 | Colman et al. | Apr 2013 | B2 |
8428966 | Green, III et al. | Apr 2013 | B2 |
8438041 | Green, III et al. | May 2013 | B2 |
20010005773 | Larsen et al. | Jun 2001 | A1 |
20010018557 | Lynn et al. | Aug 2001 | A1 |
20010020122 | Steuer et al. | Sep 2001 | A1 |
20010039376 | Steuer et al. | Nov 2001 | A1 |
20010044588 | Mault | Nov 2001 | A1 |
20010044700 | Kobayashi et al. | Nov 2001 | A1 |
20020026106 | Khalil et al. | Feb 2002 | A1 |
20020035318 | Mannheimer et al. | Mar 2002 | A1 |
20020038079 | Steuer et al. | Mar 2002 | A1 |
20020042558 | Mendelson | Apr 2002 | A1 |
20020049389 | Abreu | Apr 2002 | A1 |
20020062071 | Diab et al. | May 2002 | A1 |
20020082488 | Al-Ali et al. | Jun 2002 | A1 |
20020085952 | Ellingboe et al. | Jul 2002 | A1 |
20020091326 | Hashimoto et al. | Jul 2002 | A1 |
20020095090 | Caro et al. | Jul 2002 | A1 |
20020111748 | Kobayashi et al. | Aug 2002 | A1 |
20020128544 | Diab et al. | Sep 2002 | A1 |
20020133068 | Huiku | Sep 2002 | A1 |
20020138014 | Baura et al. | Sep 2002 | A1 |
20020156354 | Larson | Oct 2002 | A1 |
20020161287 | Schmitt | Oct 2002 | A1 |
20020161290 | Chance | Oct 2002 | A1 |
20020165439 | Schmitt | Nov 2002 | A1 |
20020165462 | Westbrook et al. | Nov 2002 | A1 |
20020198443 | Ting | Dec 2002 | A1 |
20030023140 | Chance | Jan 2003 | A1 |
20030055324 | Wasserman | Mar 2003 | A1 |
20030055331 | Kotmel et al. | Mar 2003 | A1 |
20030060693 | Monfre et al. | Mar 2003 | A1 |
20030101076 | Zaleski | May 2003 | A1 |
20030135127 | Sackner et al. | Jul 2003 | A1 |
20030139687 | Abreu | Jul 2003 | A1 |
20030144584 | Mendelson | Jul 2003 | A1 |
20030150842 | Mikame | Aug 2003 | A1 |
20030158466 | Lynn | Aug 2003 | A1 |
20030181815 | Ebner et al. | Sep 2003 | A1 |
20030220548 | Schmitt | Nov 2003 | A1 |
20030220576 | Diab | Nov 2003 | A1 |
20030228625 | Toh et al. | Dec 2003 | A1 |
20040010188 | Wasserman | Jan 2004 | A1 |
20040039295 | Olbrich et al. | Feb 2004 | A1 |
20040044276 | Arnold | Mar 2004 | A1 |
20040054270 | Pewzner et al. | Mar 2004 | A1 |
20040064020 | Diab et al. | Apr 2004 | A1 |
20040078219 | Kaylor et al. | Apr 2004 | A1 |
20040078228 | Fitzgerald et al. | Apr 2004 | A1 |
20040087846 | Wasserman | May 2004 | A1 |
20040087916 | Pickup | May 2004 | A1 |
20040107065 | Al-Ali | Jun 2004 | A1 |
20040111014 | Hickle | Jun 2004 | A1 |
20040117204 | Mazar et al. | Jun 2004 | A1 |
20040127779 | Steuer et al. | Jul 2004 | A1 |
20040158135 | Baker, Jr. et al. | Aug 2004 | A1 |
20040163648 | Burton | Aug 2004 | A1 |
20040171920 | Mannheimer et al. | Sep 2004 | A1 |
20040176670 | Takamura et al. | Sep 2004 | A1 |
20040176671 | Fine et al. | Sep 2004 | A1 |
20040181134 | Baker, Jr. et al. | Sep 2004 | A1 |
20040181196 | Pickup et al. | Sep 2004 | A1 |
20040204637 | Diab et al. | Oct 2004 | A1 |
20040230106 | Schmitt et al. | Nov 2004 | A1 |
20040249299 | Cobb | Dec 2004 | A1 |
20040254481 | Brodnick | Dec 2004 | A1 |
20040254490 | Egli | Dec 2004 | A1 |
20050001728 | Appelt et al. | Jan 2005 | A1 |
20050017864 | Tsoukalis | Jan 2005 | A1 |
20050033129 | Edgar, Jr. et al. | Feb 2005 | A1 |
20050043616 | Chinchoy | Feb 2005 | A1 |
20050065556 | Reghabi et al. | Mar 2005 | A1 |
20050070774 | Addison et al. | Mar 2005 | A1 |
20050080323 | Kato | Apr 2005 | A1 |
20050085735 | Baker, Jr. et al. | Apr 2005 | A1 |
20050101850 | Parker | May 2005 | A1 |
20050113651 | Wood et al. | May 2005 | A1 |
20050113656 | Chance | May 2005 | A1 |
20050113709 | Millet | May 2005 | A1 |
20050119586 | Coyle et al. | Jun 2005 | A1 |
20050119708 | Haefner | Jun 2005 | A1 |
20050143665 | Huiku et al. | Jun 2005 | A1 |
20050154422 | Band et al. | Jul 2005 | A1 |
20050168722 | Forstner et al. | Aug 2005 | A1 |
20050177034 | Beaumont | Aug 2005 | A1 |
20050187480 | Kario et al. | Aug 2005 | A1 |
20050192488 | Bryenton et al. | Sep 2005 | A1 |
20050192500 | Caro et al. | Sep 2005 | A1 |
20050203357 | Debreczeny et al. | Sep 2005 | A1 |
20050209521 | Kettunen et al. | Sep 2005 | A1 |
20050222503 | Dunlop et al. | Oct 2005 | A1 |
20050228248 | Dietiker | Oct 2005 | A1 |
20050245830 | Hutchinson | Nov 2005 | A1 |
20050247311 | Vacchiano et al. | Nov 2005 | A1 |
20050251056 | Gribkov et al. | Nov 2005 | A1 |
20050267346 | Faber et al. | Dec 2005 | A1 |
20050277819 | Kiani et al. | Dec 2005 | A1 |
20050283059 | Iyer et al. | Dec 2005 | A1 |
20060009688 | Lamego et al. | Jan 2006 | A1 |
20060009809 | Marcovecchio et al. | Jan 2006 | A1 |
20060015021 | Cheung | Jan 2006 | A1 |
20060020181 | Schmitt | Jan 2006 | A1 |
20060030763 | Mannheimer et al. | Feb 2006 | A1 |
20060042631 | Martin et al. | Mar 2006 | A1 |
20060052680 | Diab | Mar 2006 | A1 |
20060058683 | Chance | Mar 2006 | A1 |
20060064024 | Schnall | Mar 2006 | A1 |
20060081259 | Bruggeman et al. | Apr 2006 | A1 |
20060084854 | Cho et al. | Apr 2006 | A1 |
20060137577 | Chang et al. | Jun 2006 | A1 |
20060149144 | Lynn et al. | Jul 2006 | A1 |
20060155176 | Ebner et al. | Jul 2006 | A1 |
20060155206 | Lynn | Jul 2006 | A1 |
20060155207 | Lynn et al. | Jul 2006 | A1 |
20060161071 | Lynn et al. | Jul 2006 | A1 |
20060167363 | Osypka et al. | Jul 2006 | A1 |
20060189872 | Arnold | Aug 2006 | A1 |
20060189880 | Lynn et al. | Aug 2006 | A1 |
20060195028 | Hannula et al. | Aug 2006 | A1 |
20060195041 | Lynn et al. | Aug 2006 | A1 |
20060195149 | Hopper et al. | Aug 2006 | A1 |
20060200016 | Diab et al. | Sep 2006 | A1 |
20060217614 | Takala et al. | Sep 2006 | A1 |
20060217615 | Huiku et al. | Sep 2006 | A1 |
20060217628 | Huiku | Sep 2006 | A1 |
20060224058 | Mannheimer | Oct 2006 | A1 |
20060235324 | Lynn | Oct 2006 | A1 |
20060235726 | Paraison | Oct 2006 | A1 |
20060247501 | Ali | Nov 2006 | A1 |
20060258921 | Addison et al. | Nov 2006 | A1 |
20060276695 | Lynn et al. | Dec 2006 | A9 |
20060287590 | McEowen | Dec 2006 | A1 |
20070004957 | Hilburg | Jan 2007 | A1 |
20070010723 | Uutela et al. | Jan 2007 | A1 |
20070015976 | Miesel et al. | Jan 2007 | A1 |
20070027369 | Pagnacco et al. | Feb 2007 | A1 |
20070027375 | Melker et al. | Feb 2007 | A1 |
20070037873 | Zurier et al. | Feb 2007 | A1 |
20070073361 | Goren et al. | Mar 2007 | A1 |
20070093701 | Myers et al. | Apr 2007 | A1 |
20070093721 | Lynn et al. | Apr 2007 | A1 |
20070129647 | Lynn | Jun 2007 | A1 |
20070142719 | Kawasaki et al. | Jun 2007 | A1 |
20070149860 | Lynn et al. | Jun 2007 | A1 |
20070179350 | Nadeau | Aug 2007 | A1 |
20070179369 | Baker, Jr. | Aug 2007 | A1 |
20070191688 | Lynn | Aug 2007 | A1 |
20070191697 | Lynn et al. | Aug 2007 | A1 |
20070203406 | Anderson et al. | Aug 2007 | A1 |
20070208269 | Mumford et al. | Sep 2007 | A1 |
20070213619 | Linder | Sep 2007 | A1 |
20070213620 | Reisfeld | Sep 2007 | A1 |
20070213621 | Reisfeld et al. | Sep 2007 | A1 |
20070213622 | Reisfeld | Sep 2007 | A1 |
20070213624 | Reisfeld et al. | Sep 2007 | A1 |
20070225606 | Naghavi et al. | Sep 2007 | A1 |
20070225614 | Naghavi et al. | Sep 2007 | A1 |
20070238937 | Chang et al. | Oct 2007 | A1 |
20070240723 | Hong et al. | Oct 2007 | A1 |
20070255146 | Andrews et al. | Nov 2007 | A1 |
20070255322 | Gerber et al. | Nov 2007 | A1 |
20070282212 | Sierra et al. | Dec 2007 | A1 |
20080009689 | Benaron et al. | Jan 2008 | A1 |
20080014115 | Johns | Jan 2008 | A1 |
20080027368 | Kollar et al. | Jan 2008 | A1 |
20080036752 | Diab et al. | Feb 2008 | A1 |
20080051764 | Dent et al. | Feb 2008 | A1 |
20080064965 | Jay et al. | Mar 2008 | A1 |
20080066753 | Martin et al. | Mar 2008 | A1 |
20080082018 | Sackner et al. | Apr 2008 | A1 |
20080167540 | Korhonen et al. | Jul 2008 | A1 |
20080177163 | Wang et al. | Jul 2008 | A1 |
20080183058 | Mannheimer | Jul 2008 | A1 |
20080183083 | Markowitz et al. | Jul 2008 | A1 |
20080188729 | Sato et al. | Aug 2008 | A1 |
20080200775 | Lynn | Aug 2008 | A1 |
20080200781 | Van Herpen et al. | Aug 2008 | A1 |
20080200824 | Kane et al. | Aug 2008 | A1 |
20080208012 | Ali | Aug 2008 | A1 |
20080235049 | Morita et al. | Sep 2008 | A1 |
20080235057 | Weidenhaupt et al. | Sep 2008 | A1 |
20080269583 | Reisfeld | Oct 2008 | A1 |
20080269626 | Gallaher et al. | Oct 2008 | A1 |
20080269832 | Wong et al. | Oct 2008 | A1 |
20080275349 | Halperin et al. | Nov 2008 | A1 |
20080281168 | Gibson et al. | Nov 2008 | A1 |
20080287756 | Lynn | Nov 2008 | A1 |
20080300471 | Al-Ali et al. | Dec 2008 | A1 |
20080312533 | Balberg et al. | Dec 2008 | A1 |
20090082641 | Giftakis et al. | Mar 2009 | A1 |
20090083072 | Osawa et al. | Mar 2009 | A1 |
20090143694 | Krauss et al. | Jun 2009 | A1 |
20090177493 | Narayan | Jul 2009 | A1 |
20090281838 | Lynn et al. | Nov 2009 | A1 |
20090281839 | Lynn et al. | Nov 2009 | A1 |
20090299154 | Segman | Dec 2009 | A1 |
20090318775 | Michelson et al. | Dec 2009 | A1 |
20100026510 | Kiani et al. | Feb 2010 | A1 |
20100066540 | Theobald et al. | Mar 2010 | A1 |
20100079292 | Lynn et al. | Apr 2010 | A1 |
20100088346 | Urness et al. | Apr 2010 | A1 |
20100113909 | Batchelder et al. | May 2010 | A1 |
20100234705 | Lynn | Sep 2010 | A1 |
20100261977 | Seely | Oct 2010 | A1 |
20110009722 | Amundson et al. | Jan 2011 | A1 |
20110015501 | Lynn et al. | Jan 2011 | A1 |
20110208018 | Kiani | Aug 2011 | A1 |
20110208539 | Lynn | Aug 2011 | A1 |
20120145152 | Lain et al. | Jun 2012 | A1 |
20120328594 | McKenna et al. | Dec 2012 | A1 |
20130211214 | Olsen | Aug 2013 | A1 |
20130254717 | Al-Ali et al. | Sep 2013 | A1 |
20130262730 | Al-Ali et al. | Oct 2013 | A1 |
20130274572 | Al-Ali et al. | Oct 2013 | A1 |
20130276785 | Melker | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
2450900 | May 1975 | DE |
0934723 | Aug 1988 | EP |
0459647 | Oct 1991 | EP |
0459284 | Dec 1991 | EP |
0615723 | Mar 1993 | EP |
0666056 | Jul 1994 | EP |
0392503 | May 1995 | EP |
0684011 | May 1995 | EP |
0700690 | Mar 1996 | EP |
0759791 | Mar 1997 | EP |
0875258 | Nov 1998 | EP |
1172123 | Jan 2002 | EP |
1905356 | Sep 2007 | EP |
1554829 | Feb 1978 | GB |
63275325 | Nov 1988 | JP |
05266002 | Mar 1992 | JP |
2000-042111 | Feb 2000 | JP |
2004145853 | May 2004 | JP |
2005034472 | Feb 2005 | JP |
2006519626 | Aug 2006 | JP |
WO 9212750 | Aug 1992 | WO |
WO 9316629 | Sep 1993 | WO |
WO 9639927 | Dec 1996 | WO |
WO 9719719 | Jun 1997 | WO |
WO 9843071 | Oct 1998 | WO |
WO 9913766 | Mar 1999 | WO |
WO 0021438 | Apr 2000 | WO |
WO 0140776 | Jun 2001 | WO |
WO 0176461 | Oct 2001 | WO |
WO 0176471 | Oct 2001 | WO |
WO 0187149 | Nov 2001 | WO |
WO 0241771 | May 2002 | WO |
WO 03039326 | May 2003 | WO |
WO 03053780 | Jul 2003 | WO |
WO 2004056301 | Jul 2004 | WO |
WO 2004080300 | Sep 2004 | WO |
WO 2005037077 | Apr 2005 | WO |
WO 2005056087 | Jun 2005 | WO |
WO 2005065540 | Jul 2005 | WO |
WO 2006086010 | Aug 2006 | WO |
WO 2006116469 | Nov 2006 | WO |
WO 2007013708 | Feb 2007 | WO |
WO 2007131064 | Nov 2007 | WO |
WO 2007131066 | Nov 2007 | WO |
WO 2008008163 | Jan 2008 | WO |
Entry |
---|
Author Unknown, FiO2, Wikipedia Encyclopedia, modified Oct. 30, 2007 . . . http://en.wikipedia.org/wiki/FiO2. |
Cirignotta, Fabio, Cerebral Anoxic Attacks in Sleep Apnea Syndrome, Sleep, 1989, pp. 400-404, vol. 12 No. 5. |
Curry, J. Paul, Threshold Monitoring, Alarm Fatigue, and the Patterns of Unexpected Hospital Death, APSF Newsletter, Fall 2011, pp. 32-35. |
Davidson Ward, Sally et al., Responses to hypoxia and hypercapnia in infants of substance-abusing mothers, The Journal of Pediatrics, 1992, pp. 704-709, vol. 121 No. 5 Pt. 1. |
Diagnostic Apparatus, Bibliographic Data: JP63275325A, Publication Date Nov. 14, 1988, 12 pages. |
Doherty, L. S et al., Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome, Chest, Jun. 2005, vol. 127, No. 6, pp. 2076-2084 (Abstract). |
Horne, Rosemary S.C. et al., Arousal responses and risk factors for sudden infant death syndrome, Sleep Medicine 3, 2002, Supplement, pp. S61-S65. |
Horne, Rosemary S.C. et al., Effects of Prematurity on Arousal from Sleep in the Newborn Infant, Pediatric Research, 2000, pp. 468-474, vol. 47 No. 4. |
Intensive Care Ventilators, Product Comparison by Healthcare Product Comparison Systems, Inc. published by ECRI, Apr. 2006, 71 pages. |
International Application No. PCT/US2009/059102, Written Opinion of the International Searching Authority, date of Issue Apr. 5, 2011. |
Lung Volumes, Wikipedia, available at http://en.wikipedia.org/wiki/Tidal—volume, printed on Nov. 15, 2007, 4 pages. |
McEwen, James et al., Detection of Interruptions in the Breathing Gas of Ventilated Anaesthetized Patients, Canadian Journal of Anaesthology, 1988, vol. 35, No. 6, pp. 549-561. |
Newman, N. M., Arousal defect: Mechanism of the Suddent Infant Death Syndrome?, Australian Pediatric Journal, 1989, pp. 196-201. |
Rivera, Luis, MD et al., Dynamic Ventilatory Characteristics During Weaning in Postoperative Critically Ill Patients, Anesthesia & Analgesia, 1997, vol. 84, pp. 1250-1255. |
Stacey, Michael et al., “Temporal abstraction in the intelligent clinical data analysis: A survey,” Artificial Intelligence in Medicine, 2007, vol. 19, pp. 1-24. |
Abelson, Harold et al., Structure and Interpretation of Computer Programs, MIT Press, 2nd Edition, 1996, p. 99-107, 113-126. |
Agronsky, Dominik, et al., Diagnosing Community-Acquired Pneumonia with a Bayesian Network, AMIA, Inc., 1998, pp. 632-636. |
Appeal Brief for U.S. Appl. No. 11/351,961, filed Sep. 24, 2009. |
Brabrand, Mikkel, et al., Risk scoring systems for adults admitted to the emergency department: a systematic review, Scandinavian Journal of Trauma, Resuscitation & Emergency Medicine, Retrieved from <http://www.sjtrem.com/content/18/1/8>, 2010, pp. 1-8. |
Caines et al: “Overlooking orthostatic hypotension with routine blood-pressure equipment” 1 Lancet the Lancet Limited. London, GB, vol. 352, No. 9126, Aug. 8, 1998, p. 458, DXP004832973, ISSN:0140-6736, the whole document. |
Capuano, Terry Ann, et al., Remote Telemetry, Nursing Management, Vo. 26, No. 7, Jul. 1995, p. 26. |
Charbonnier et al., “A trend-based alarm system to improve patient monitoring in intensive care units,” Control Engineering Practice, Pergamon Press, Oxford, GB, vol. 15, No. 9, May 12, 2007; pp. 1039-1050. |
Crowe, Colleen A., et al., Comparison of severity of illness scoring systems in the prediction of hospital mortality in severe sepsis and septic shock, Journal of Emergencies, Trauma, and Shock, Oct.-Dec. 2010, pp. 342-347, Oak Lawn, IL, USA. |
Diep, Binh An, et al., Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury, PNAS, Mar. 23, 2010, vol. 107, No. 12, pp. 5587-5592. |
Doctors use ‘remote control’ to monitor ICU patients, CNN.com. technology>computing, Aug. 21, 2000, http://www.cnn .com/2000/TEC H/computing/08/21/icu. t—t l. |
Earthrowl-Gould, T., et al.; “Chest and abdominal surface motion measurement for continuous monitoring of respiratory function,” Proc. lnstn Mech Engrs, V215, Part H; pp. 515-520 (2001). |
East, Christine E., et al.; “Fetal Oxygen Saturation and Uterine Contractions During Labor,” American Journal of Perinatology, vol. 15, No. 6, pp. 345-349 (Jun. 1998). |
Examiner's Answer for U.S. Appl. No. 11/351,961, mailed Jan. 4, 2010. |
Ferrari, A U, et al., Inverse Relationship between heart rate and blood pressure variabilities in rats. Hypertension. Nov. 1987, vol. 10, No. 5, pp. 533-537. |
Final Office Action for U.S. Appl. No. 11/351,961, mailed Apr. 24, 2009. |
Finding Value in Intensive Care, From Afar, The New York Times on the Web, Jul. 27, 1999, www.Visicu.com/ companynews/0799—nytimes.htm. |
Fry, Donald, et al., The Changing Face of Staphylococcus aureus: A Continuing Surgical Challenge, Surgical Infections, 2011, vol. 12, No. 3, pp. 191-203. |
Ghanem-Zoubi, Nesrin, et al., Assessment of disease-severity scoring systems for patients with sepsis in general internal medicine departments, Critical Care, Retrieved from <http://ccforum.com/content/15/2/R95>, 2011, pp. 1-7. |
Grundy, Betty L., et al., Telemedicine in Critical Care: An Experiment in Health Care Delivery, JACEP, vol. 6, Oct. 1977, pp. 439-444. |
Hornero, Roberto, et al.; “Utility of Approximate Entropy From Overnight Pulse Oximetry Data in the Diagnosis of the Obstructive Sleep Apnea Syndrome,”; IEEE Transactions on Biomedical Engineering, vol. 54, No. 1, pp. 107-113, Jan. 2007. |
International Preliminary Report on Patentability Including Written Opinion for International (PCT) Patent Application No. PCT/US2009/043150, issued Nov. 9, 2010 9 pages. |
International Preliminary Report on Patentability including Written Opinion for International (PCT) Patent Application No. PCT/US2009/064312, issued May 31, 2011 10 pages. |
International Search Report and Written Opinion for application No. PCT/GB2010/001624 dated Dec. 7, 2010. |
International Search Report for International (PCT) Patent Application No. PCT/US2009/043150, mailed Aug. 4, 2009 2 pages. |
International Search Report for International (PCT) Patent Application No. PCT/US2009/064312, mailed Feb. 26, 2010 3 pages. |
International Search Report for International (PCT) Patent Application No. PCT/US2012/065124, mailed Mar. 25, 2013, 10 pages. |
International Search Report for International (PCT) Patent Application No. PCT/US2012/065129, mailed Mar. 20, 2013, 12 pages. |
International Search Report, PCT/US2008/002253; Date of mailing: Jun. 9, 2008. |
International Search Report, PCT/US2008/002254, Date of Mailing: Jul. 28, 2008. |
Johansson, A.; “Neural network for photoplethysmographic respiratory rate monitoring,” Medical & Biological Engineering & Computing, vol. 41, pp. 242-248 (2003). |
Johnston, W.S., et al.; “Extracting Breathing Rate information from a Wearable Reflectance Pulse Oximeter Sensor,” Proceedings of the 26th Annual International conference of the IEEE EMBS, San Francisco, California; Sep. 1-5, 2004; pp. 5388-5391. |
Kaplan, Simon M. and Geraldine Fitzpatrick, Designing Support for Remote Intensive-Care Telehealth Using the Locales Framework, ACM, 1997, pp. 173-184. |
Kellett, J., et al., The Simple Clinical Score predicts mortality for 30 days after admission to an acute medical unit, Retrieved from <http://qjmed.oxfordjornals.org>, Q J Med, Received Apr. 17, 2006 and in revised form Jul. 3, 2006, pp. 771-781, vol. 99, Published by Oxford University Press on behalf of the Association of Physicians, Nenagh, Ireland. |
Kreisel. Kristen, et al., USA300 Methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 Methicillin-resistant Staphylococcus aureus associated with more severe infections?, Diagnostic Microbiology and Infectious Disease, 2011, vol. 70, pp. 285-290. |
Lappin, Emma, et al., Gram-Positive Toxic Shock Syndromes, The Lancet, May 2009, vol. 9, pp. 281-290. |
Lee, Ho Sung, et al., Remote Patient Monitoring Service through World-Wide Web, Proceedings—19th International Conference—IEEE/EMBS, Oct. 3D-Nov. 2, 1997, pp. 928-931. |
Levy, Mitchell M., et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, Critical Care Medicine, 2003, pp. 1250-1256, vol. 31 No. 4. |
Mabry, Susan L., et al., Integrated Medical Analysis System, Proceedings of the 1997 Winter Simulation Conference, , 1997, pp. 1167-1168. |
Maletras, Francois-Xavier, et al.; “Construction and calibration of a new design of Fiber Optic Respiratory Plethysmograph (FORP),” Optomechanical Design and Engineering, Proceedings of SPIE, vol. 4444, pp. 285-293 (2001). |
Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Critical Care Medicine, 1992, pp. 864-874, vol. 20 No. 6. |
Miksch, Silvia, Artificial Intelligence for Decision Support: Needs, Possibilities, and Limitations in ICU, 10th Postgraduate Course in Critical Care Medicine A.P.I.C.E. '95, Springer, 1995, pp. 1-11. |
Nenov, Valeriy and John Klopp, Remote Access to Neurosurgical CU Physiological Data using the World Wide web, health Care in the Information Age, 1996, pp. 242-249. |
Nguyen, H. Bryant, et al., Severe Sepsis and Septic Shock: Review of the Literature and Emergency Department Management Guidelines, Annals of Emergency Medicine, Jul. 2006, vol. 48, No. 1, pp. 28-55. |
Nilsson, Lena, et al.; “Monitoring of Respiratory Rate in Postoperative Care Using a New Photoplethysmographic Technique,” Journal of Clinical Monitoring and Computing, vol. 16, pp. 309-315 (2000). |
Non-Final Office Action for U.S. Appl. No. 11/351,961, mailed Aug. 19, 2008. |
Notice of Allowability for U.S. Appl. No. 10/150,582, mailed Feb. 13, 2006. |
Notice of Allowance for U.S. Appl. No. 11/455,408, mailed Jan. 23, 2012 8 pages. |
Notice of Allowance for U.S. Appl. No. 11/455,488, mailed Aug. 22, 2011 8 pages. |
Notice of Allowance for U.S. Appl. No. 11/455,488, mailed Nov. 29, 2011 8 pages. |
Official Action for Canada Patent Application No. 2,678, 776, dated Feb. 8, 2012. |
Official Action for Canada Patent Application No. 2,678,856, mailed Feb. 2, 2012 3 pages. |
Official Action for U.S. Appl. No. 10/150,582, mailed Jun. 20, 2005. |
Official Action for U.S. Appl. No. 11/274,960, mailed Jun. 8, 2010. |
Official Action for U.S. Appl. No. 11/274,960, mailed Oct. 20, 2010. |
Official Action for U.S. Appl. No. 11/280,559, mailed Mar. 21, 2011 13 pages. |
Official Action for U.S. Appl. No. 11/280,559, mailed Oct. 5, 2011 12 pages. |
Official Action for U.S. Appl. No. 11/280,653, mailed Dec. 1, 2010 9 pages. |
Official Action for U.S. Appl. No. 11/280,653, mailed Jun. 13, 2011 8 pages. |
Official Action for U.S. Appl. No. 11/280,653, mailed Mar. 31, 2010. |
Official Action for U.S. Appl. No. 11/351,787, mailed Apr. 22, 2011 11 pages. |
Official Action for U.S. Appl. No. 11/351,787, mailed Nov. 12, 2010. |
Official Action for U.S. Appl. No. 11/351,961, mailed Apr. 24, 2009. |
Official Action for U.S. Appl. No. 11/351,961, mailed Aug. 19, 2008. |
Official Action for U.S. Appl. No. 11/351,961, mailed Jan. 4, 2010. |
Official Action for U.S. Appl. No. 11/369,355, mailed Aug. 18, 2011 8 pages Restriction Requirement. |
Official Action for U.S. Appl. No. 11/369,355, mailed Jan. 6, 2012 8 pages. |
Official Action for U.S. Appl. No. 11/369,379, mailed Jun. 20, 2011 8 pages. |
Official Action for U.S. Appl. No. 11/455,408, mailed Dec. 27, 2010. |
Official Action for U.S. Appl. No. 11/455,408, mailed Jul. 27, 2011 6 pages. |
Official Action for U.S. Appl. No. 11/455,488, mailed Dec. 28, 2010. |
Official Action for U.S. Appl. No. 12/437,385, mailed Apr. 5, 2011 22 pages. |
Official Action for U.S. Appl. No. 12/437,385, mailed Nov. 25, 2011 18 pages. |
Official Action for U.S. Appl. No. 12/437,417, mailed Mar. 4, 2011 24 pages. |
Official Action for U.S. Appl. No. 12/839,177, mailed Nov. 21, 2011 12 pages. |
Patel, M.S., et al., Does the use of a “track and trigger” warning system reduce mortality in trauma patients?, Injury, D May 25, 2011, doi:1 0.1 016/j.injury.2011.05.030, pp. 1-5, Elsevier Ltd., United Kingdom. |
Perednia, Douglas A., Telemedine Technology and Clinical Applications, JAMA, vol. 6, Feb. 8, 1995, p. 483. |
Pickett, John, et al.; “Pulse Oximetry and PPG Measurements in Plastic Surgery,” Proceedings—19th International Conference—IEEE/EMBS, Chicago, Illinois, Oct. 30-Nov. 2, 1997, pp. 2330-2332. |
Remote Monitoring of ICU Patients Lowers Mortality Rates, Complications, Johns Hopkins Newsrelease, Mar. 20, 2001 , http ://www.newswise. com/articles/2001/3/ICU.JHM.html. |
Response to Non-Final Office Action for U.S. Appl. No. 11/351,961, filed Dec. 19, 2008. |
Restriction Requirement for U.S. Appl. No. 11/369,355, mailed Sep. 2, 2010. |
Restriction Requirement for U.S. Appl. No. 11/274,960, mailed Feb. 3, 2010. |
Restriction Requirement for U.S. Appl. No. 11/280,559, mailed Mar. 4, 2010. |
Restriction Requirement for U.S. Appl. No. 11/280,559, mailed Oct. 18, 2010. |
Restriction Requirement for U.S. Appl. No. 11/351,787, mailed Jul. 9, 2010. |
Restriction Requirement for U.S. Appl. No. 11/369,355, mailed Dec. 8, 2010. |
Restriction Requirement for U.S. Appl. No. 11/369,379, mailed Dec. 27, 2010. |
Restriction Requirement for U.S. Appl. No. 11/369,379, mailed Sep. 20, 2010. |
Restriction Requirement for U.S. Appl. No. 11/455,408, mailed Sep. 30, 2010. |
Restriction Requirement for U.S. Appl. No. 11/455,488, mailed Sep. 16, 2010. |
Rosenfeld, M.D., Brian A., FCCM, FCCP, et al., Intensive care unit telemedicine: Alternate paradigm for providing continuous intensive care, Critical Care Medicine, vol. 28, No. 12, 2000 p. 3925. |
Sawyer, Amber M., et al., Implementation of a real-time computerized sepsis alert in no intensive care unit patients, Critical Care Medicine, 2011, pp. 469-4 73, vol. 39, No. 3 D. |
Seelbach-Gobel, Birgit, et al.; The prediction of fetal acidosis by means of intrapartum fetal pulse oximetry, Am J. Obstet. Gynecol., vol. 180, No. 1, Part 1, pp. 73-81 (1999). |
Seigel, Todd A., et al., Inadequacy of Temperature and White Blood Cell Count in Predicting Bacteremia in Patients D with Suspected Infection, 2010, Elsevier, Inc., The Journal of Emergency Medicine, pp. 1-6, 2010. |
Spigulis, Janis, et al.; “Optical multi-channel sensing of skin blood pulsations,” Optical Sensing, Proceedings of SPIE, vol. 5459, pp. 46-53 (2004). |
Subbe, C. P., et al., Validation of a modified Early Warning Score in medical admissions, Original Papers, Q J Med, D May 17, 2001 and in revised form Jul. 9, 2001, pp. 521-526, vol. 94, Association of Physicians. |
Tufte, Edward R., The Visual Display of Quantitative Information (Graphics Press, 1983), p. 17, 21, 153. |
U.S. Appl. No. 11/431,686, Amendment and Response to NF Office Action, filed Jun. 21, 2011. |
U.S. Appl. No. 11/431,686, Final Office Action, dated Oct. 12, 2011. |
U.S. Appl. No. 11/431,686, NF Office Action, dated Jan. 21, 2011. |
U.S. Appl. No. 11/431,686, Office Action (Restriction Requirement), dated Sep. 30, 2010. |
U.S. Appl. No. 11/431,686, Request for Continued Examination and Preliminary Amendment, filed Feb. 29, 2012. |
U.S. Appl. No. 11/431,686, Response to Restriction Requirement, filed Oct. 29, 2010. |
U.S. Appl. No. 12/437,385, Amendment and Response to NF Office Action, dated Jan. 15, 2013. |
U.S. Appl. No. 12/437,385, Amendment and Response to NF Office Action, dated Sep. 6, 2011. |
U.S. Appl. No. 12/437,385, Final Office Action, dated Nov. 25, 2011. |
U.S. Appl. No. 12/437,385, NF Office Action, dated Apr. 5, 2011. |
U.S. Appl. No. 12/437,385, NF Office Action, dated Aug. 17, 2012. |
U.S. Appl. No. 12/437,385, Request for Continued Examination and Preliminary Amendment, filed Feb. 7, 2012. |
U.S. Appl. No. 12/437,417, Amendment and Response to NF Office Action, dated Nov. 5, 2012. |
U.S. Appl. No. 12/437,417, Amendment and Response to NF Office Action, dated Sep. 6, 2011, 13 pages. |
U.S. Appl. No. 12/437,417, Final Office Action, dated Feb. 14, 2013. |
U.S. Appl. No. 12/437,417, NF Office Action, dated Aug. 3, 2012. |
U.S. Appl. No. 12/437,417, Final Office Action, dated Nov. 29, 2011. |
U.S. Appl. No. 12/437,417, Request for Continued Examination and Preliminary Amendment, filed Feb. 29, 2012. |
U.S. Appl. No. 12/629,407, Amendment and Response to NF Office Action dated Sep. 25, 2012, filed Feb. 21, 2013. |
U.S. Appl. No. 12/629,407, NF Office Action, dated Aug. 16, 2012. |
U.S. Appl. No. 12/629,407, NF Office Action, dated Sep. 25, 2012. |
U.S. Appl. No. 12/629,407, Response to Requirement for Restriction, filed Sep. 14, 2012. |
Wile, Michael J., et al., Manual Differential Cell Counts Help Predict Bacterial Infection, a Multivariate Analysis, D Hematopathology, 2001, pp. 644-649, vol. 115, Am J Clin Pathol. |
Yoon, Gilwon, et al.; Multiple diagnosis based on Photo-plethysmography: hematocrit, Sp02, pulse and respiration, Optics in Health Care and Biomedical optics: Diagnostics and Treatment; Proceedings of the SPIE, vol. 4916; pp. 185-188 (2002). |
Alaris System, Brochure, Medication Safety System Focused at the Point of Care, Cardinal Health, Alaris Products, pp. 8, 2004. |
Alian, Aymen et al., Evaluation of Rapid Response Team Flag-Alert Parameters, Published on www.cardiopulmonarycorp.com/pdf/rapidresponsealert—paramers.pdf referenced in 2008, Internet Publication 2010. |
Author Unknown, Chapter IV Oxygen Consumption During ADO, Introduction, pp. 40-46, Book Title Unknown, Study published 1980. |
Author Unknown, Chapter X Effects of a 6-minute Period of ADO, Introduction, pp. 108-113, Book Title Unknown, Study published 1980. |
Author Unknown, Hospital Inpatient Chart, Completed prior to 2011, not published. |
Avance Innovating with you, shaping exceptional care, Brochure, GE Healthcare, pp. 8, 2006. |
Bartolo, Anton et al., An Arrhythmia Detector and Heart Rate Estimator for Overnight Polysomnography Studies, conditionally accepted for IEEE Transactions, 19 pages, Nov. 3, 2000. |
Benumof, Jonathan L., Creation of Observational Unit May Decrease Sleep Apnea Risk, Letters to the Editor, Anesthesia Patient Safety Foundation Newsletter and posted on the Malpractice company's web site. The Doctors Company I Sleep Apnea and Narcotic Postoperative Paln . . . http://www.thedoctors.com/risk/bulletins/sleepapnea.asp, 2002: 17:39. |
Buckle, Patricia et al., Polysomnography in Acutely Ill Intensive Care Unit Patients, Chest, v. 102 n. 1, p. 288 (4), American College of Chest Physicians, Jul. 1992. |
Centiva/5 Critical Care Ventilator, Brochure, GE Healthcare, pp. 8, Oct. 2005. |
Chi, Time-Series Matrices, University of Minnosota, http://www-users.cs.umn.edu/-echi/papers/infovis97/spread/node13.html, 1997, pp. 1-3. |
Critical Care Therapy and Respiratory Care Section Policy, National Institute of Health, pp. 7, revised Mar. 2000. |
Daley, Denise M., MD, Beware of All Sedatives in Patients With Sleep Apnea, Anesthesia Patient Safety Foundation Newsletter and posted on the Malpractice company's web site. The Doctors Company, Sleep Apnea and Narcotic Postoperative Pain . . . http://www.thedoctors.com/risk/bulletins/sleepapnea.asp, Letters to the Editor 2002-2003. |
Datex-Phmeda Output Protocols Ohmeda Corn 1.0 Serial Protocol, Brochure, Datex-Ohmeda, Version 1.5, pp. 31. Aug. 14, 2001. |
Dempsey, Jerome A. et al., Sleep and Breathing State of the Art Review Sleep-Induced Breathing Instability, Sleep, vol. 19, No. 3, pp. 236-247, American Sleep Disorders Association and Sleep Research Society, 1996. |
Ferber, Richard et al., Portable Recording in the Assessment of Obstructive Sleep Apnea, ASDA Standards of Practice, American Sleep Disorders Association, vol. 17, No. 4, pp. 378-392, 1610 14th Street, NW, Suite 300, Rochester, MN 55901-2200, USA, 1994. |
Fisher, Kyle S., MD, Value of Pulse Oximetry Monitoring on the Ward is Questioned, Anesthesia Patient Safety Foundation Newsletter and posted on the Malpractice company's web site. The Doctors Company | Sleep Apnea and Narcotic Postoperative Pain . . . http://www.thedoctors.com/risk/bulletins/sleepapnea.asp, Fall 2002. |
Henderson, L. J. et al., Blood as a Physicochemical System. II, pp. 426-431, Paper, 1924. |
Jain, Sanjay S. et al., Perioperative Treatment of Patients with Obstructive Sleep Apnea, Current Opinion Pulmonary Medicine 10, pp. 482-488, 2004. |
Kaplan, Joseph et al., Home Pulse Oximetry as a Screening Test for Sleep-Disordered Breathing, Chest, vol. 103, pp. 322S, Northbrook, IL, USA, 1993. |
Lynn, Lawrence, Background of Oximetry Utilization for Sleep Apnea Diagnosis, Publication information unknown, Article Written 1994, Not published. |
Lynn, Lawrence A. et al., History of Threshold Oximetry, First viewing of Article Apr. 11, 2009, not published. |
Lynn, Lawrence A. et al., Piercing the Panacea of Pulse Oximetry, Article Written Jul. 24, 2006, 8 pages, Not published. |
Lynn, Lawrence, The Physiologic Parameters Defining the Oximetry Waveform Patterns in Sleep Apnea, Article Written 1994, Not published. |
Lynn, Lawrence et al., Patterns of Unexpected In-Hospital Deaths: A Root Cause Analysis, Patient Safety in Surgery, vol. 5, No. 3, pp. 1-25, Feb. 11, 2011. |
Final Official Action for U.S. Appl. No. 12/629,407, mailed Jul. 17, 2013 14 pages. |
Final Office Action for U.S. Appl. No. 13/603,659, dated Sep. 25, 2013, 8 pages, English. |
Non-Final Official Action for U.S. Appl. No. 11/369,355, dated Sep. 17, 2013 8 pages, English. |
Patil, Ramesh S. et al., Application of an Artificial Intelligence Program to Therapy of High Risk Surgical Patients, New Horizons, vol. 4, No. 4, pp. 541-550, 1996. |
Redline, Susan et al., Hypopnea, a Floating Metric: Implications for Prevalence, Morbidity Estimates, and Case Finding, Sleep, vol. 20, No. 12, pp. 1209-1217, 1997. |
Ruchala, Joanna B., Chapter 13, Applications of Pulse Oximetry, Book: Design of Pulse Oximeters, pp. 214-236, Oct. 1997. |
Sadeh, Avi et al., The Role of Actigraphy in the Evaluation of Sleep Disorders, an American Sleep Disorders Association and Sleep Research Society, Sleep, vol. 18, No. 4, pp. 288-302, 1995. |
Scharf, Steven M. et al., Cardiovascular Effects of Periodic Occlusions of the Upper Airways in Dogs, American Review of Respiratory Disease, pp. 321-329, Aug. 1992. |
Shneerson J, Obstructive Sleep Apnoea, BMJ, pp. 315-367 (Aug. 9, 1997); http://bmLcom/Shneerson et al. (7104). |
Siggaard-Anderson, O et al., Editorial: The Bohr Effect and the Haldane Effect, Publication information unknown, 1973. |
Strohl, Kingman P. et al., Physiologic Basis of Therapy for Sleep Apnea, State of Art: Physiologic Basis of Therapy for Sleep Apnea, pp. 791-802, 1986. |
Tatevossian, Raymond G. et al. Noninvasive Hemodynamic Monitoring for Early Warning of Adult Respiratory Distress Syndrome in Trama Patients, Journal of Critical Care, vol. 15, No. 4 (Dec.), 2000, pp. 151-159. |
Thorpy, Michael et al., ASDA Standards of Practice, Practice Parameters for the Use of Portable Recording in the Assessment of Obstructive Sleep Apnea, Standards of Practice Committee of the American Sleep Disorders Associate, Sleep, vol. 17, No. 4, pp. 372-377, 1994. |
Wilkins, Robert L. et al., Egan's Fundamentals of Respiratory Care, Analysis and Monitoring of Gas Exchange, Book, Eighth Edition, Chapter 16, Section III, Capnography/Capnometry During Mechanical Ventilation, pp. 383-389, 2003. |
Williams et al., Screening for Sleep Apnea Using Pulse Oximetry and a Clinical Score, Chest, 100/3, Sep. 1991, pp. 631-635. |
Campbell, Beverly, Arterial Waveforms: Monitoring Changes in Configuration, Hemodynamics, Heart & Lung, May/Jun. 1997, vol. 26, No. 3, pp. 204-214. |
Number | Date | Country | |
---|---|---|---|
20120330118 A1 | Dec 2012 | US |
Number | Date | Country | |
---|---|---|---|
60291692 | May 2001 | US | |
60291687 | May 2001 | US | |
60295484 | Jun 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11369355 | Mar 2006 | US |
Child | 13603659 | US | |
Parent | 10150582 | May 2002 | US |
Child | 11369355 | US |